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Abstract
Alcoholism is a chronic relapsing disorder. Major characteristics observed in alcoholics during an
initial period of alcohol abstinence are altered physiological functions and a negative emotional
state. Evidence suggests that a persistent, cumulative adaptation involving a kindling/allostasis-
like process occurs during the course of repeated chronic alcohol exposures that is critical for the
negative symptoms observed during alcohol withdrawal. Basic studies have provided evidence for
specific neurotransmitters within identified brain sites being responsible for the negative emotion
induced by the persistent cumulative adaptation following intermittent-alcohol exposures. After an
extended period of abstinence, the cumulative alcohol adaptation increases susceptibility to stress-
and alcohol cue-induced negative symptoms and alcohol seeking, both of which can facilitate
excessive ingestion of alcohol. In the alcoholic, stressful imagery and alcohol cues alter
physiological responses, enhance negative emotion, and induce craving. Brain fMRI imaging
following stress and alcohol cues has documented neural changes in specific brain regions of
alcoholics not observed in social drinkers. Such altered activity in brain of abstinent alcoholics to
stress and alcohol cues is consistent with a continuing ethanol adaptation being responsible.
Therapies in alcoholics found to block responses to stress and alcohol cues would presumably be
potential treatments by which susceptibility for continued alcohol abuse can be reduced. By
continuing to define the neurobiological basis of the sustained alcohol adaptation critical for the
increased susceptibility of alcoholics to stress and alcohol cues that facilitate craving, a new era is
expected to evolve in which the high rate of relapse in alcoholism is minimized. 250
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1.1. Alcoholism as a disease—relationship to alcohol responsiveness, genetics, and stress
Rhem et al. (2009) recently reviewed the extreme burden of alcohol use on society—a
circumstance long recognized but inadequately addressed. Progress initiated in the middle of
the 20th century began to provide views concerning the possible basis of alcoholism. One of
the early conclusions was that offspring from a family with alcoholism were more likely to
become alcoholic (Cadoret, 1980; Cotton, 1979; Devor and Cloninger, 1989; Schukit et al.,
1985). One important biological clue linking this familial relationship to alcoholism was a
lesser susceptibility for alcohol-induced ataxia and sway in sons of alcoholics compared to
the response in individuals whose fathers were negative for alcoholism (Schukit, 1985,
1988Schukit, 1994, 2009ab. The logic gleaned from this work was that susceptible
individuals become alcoholic because they can drink more alcohol before noting
intoxication (Schukit, 1994). This view concerning the degree of alcohol intake received
further support from knowledge that Asian individuals who became ill upon ingestion of
small amounts of alcohol were less likely to become alcoholic (Peng et al., 2007). Thus, as a
credible basis for the liability for alcoholism, this concept that sons of alcoholics could
ingest more alcohol before observing symptoms of alcohol intoxication implicated a genetic
susceptibility in alcoholism (Cloninger et al., 1981; Devor and Cloninger, 1989; Schuckit et
al., 1985; Schweinsburg et al., 2004). A genetic basis is currently believed to be responsible
for more than 50% of the individual risk for becoming alcoholic (Dick and Bierut, 2006).
Ultimately such observations concerning a familial relationship to alcoholism have led to
extensive investigations to identify specific gene changes that may relate to an increased
susceptibility for this disease state (Bierut et al., 2010; Dick and Bierut, 2006; Edenberg and
Foroud, 2006; Heilig, 2008; Ramchandani et al., 2010; Shuckit, 2009a).
In recent years, another population identified with a greater susceptibility for alcoholism
includes individuals who drink alcohol excessively during adolescence (Barr et al., 1998;
Behrendt et al., 2008; Brown and Tapert, 2004; Clapper et al., 1995; Dawson et al., 2007,
2008; Dewit et al., 2000; Grant and Dawson, 1997; Hingson et al., 2006; Tapert et al., 2003).
In an effort to understand this association, studies found that the excess drinking during
adolescence that contributed to the increased vulnerability of this population for alcoholism
involved such factors as a shared environment and genetic susceptibility (Dawson et al.,
2008; Hopfer et al., 2003; McGue and Iacono, 2008; Nelson et al., 2010; Prescott and
Kendler, 1999; Rangaswamy et al., 2007).
Another generalization concerning susceptibility for alcoholism is that a stressful
environment may contribute to excessive use of alcohol (Breese et al., 2004, 2005c; Brown
et al, 1990; 1995; Kofoed et al., 1993; Koob, 2008; Sillaber and Henniger, 2004; Tate et al.,
2005; Uhart and Wand, 2008). One of the earliest views to explain the role of stress in
alcoholism was the tension-reduction hypothesis (Cappel and Herman, 1972; Conger, 1951;
1956). This concept proposed that individuals drank to reduce stress-induced tension and
anxiety. While the pharmacology of alcohol can be viewed as demonstrating an “anti-
tension” action (Gilman et al., 2008), the logic has long been questioned whether this
property of alcohol to reduce “tension” alone relates to an excess of alcohol ingestion that
ultimately produces an alcoholic state. In spite of the uncertainty of the tension-reduction
hypothesis to alcoholism, the Marlatt laboratory examined the relationship of drinking to
stress and consistently demonstrated that exposure to stress resulted in greater drinking in
college students (Higgins and Marlatt, 1973; 1975; Marlatt and Gordon, 1980; Marlatt et al,
1975).
Cooper et al. (1992) suggested that some vulnerable individuals drink as a coping
mechanism to overcome the consequence of stress. In this respect, individuals who drink
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alcohol for self-medication of symptoms of stress associated with existing psychiatric
disorders such as depression, generalized anxiety disorder, social phobia or post-traumatic
stress disorder have a higher degree of alcoholism (Collimore et al., 2010; Conway et al.
2006; Gilbertson et al., 2008; Grant et al., 2004; McLeod et al., 2001; Petrakis et al., 2002;
Pirkola et al., 2005; Schuckit, 2006, 2009b; Shivani et al., 2002). Like alcoholics (Haddad,
2004; Wand and Dobs, 1991), these disorders have a dysregulation of the HPA axis (Nestler
et al., 2002; Yehuda, 2001); however, it is unknown whether this dysregulation could
influence susceptibility for alcoholism. Further not clear is whether a pre-existing genetic
background for alcoholism may also be a contributing factor to excessive alcohol use in this
psychiatric population. In these subjects, onset of alcohol use is typically later in life, and is
predominantly driven by an ability of alcohol to transiently alleviate negative emotional
states. Alcohol intakes in this population who drink for self-medication of symptoms use
alcohol initially to dampen negative emotions—a coping mechanism. Subsequent drinking
becomes excessive resulting in adaptive change that sensitizes stress-relevant brain systems
—a change which enhances the incentive for further increases in alcohol to diminish
escalating negative symptoms to stress that occur during alcohol abstinence (Heilig, 2008).
In a comprehensive model of stress as a factor in risk and relapse to alcoholism, Sinha
(2001, 2008a, b, 2009) presents stress as a broader risk factor in the initiation and escalation
of alcohol abuse that goes beyond self-medication of co-morbid psychiatric disorders, but
rather discusses genetic risk and stress/adversity environment interactions that increase
susceptibility for addiction. Such shared risk affects the reinforcing effects of alcohol and
results in escalation of alcohol abuse. Furthermore, stress is proposed to reciprocally affect
alcohol-related neuroadaptation. Such neuroadaptation in alcohol-dependent individuals is
also manifested during abstinence as functional changes to stress and alcohol cues which
induce craving that can increase vulnerability for relapse. Details concerning this alcoholic
susceptibility to stress in relation to relapse are outlined in Sections 5 and 6. Thus, from the
early tension-reduction hypothesis to the present views of stress in alcoholism being
associated with genetic and co-morbitity with selected stress disorders and with stress
facilitating negative symptoms during abstinence to sustain alcoholism, there has been
continuing progress in defining a potential role of stress in alcohol abuse disorders.
Irrespective of the potential underlying basis for the susceptibility to drink, alcoholism is
clearly related to excessive ingestion of alcohol over time—a circumstance which ultimately
is responsible for the lack of control individuals have for minimizing alcohol intake.
Alcoholics who attempt not to drink have a remarkable history of relapse ranging from 50 to
90% depending in part upon treatment (Hunt et al., 1971; Bradizza et al., 2006; Charney et
al., 2010; Dawson et al., 2007; McKay et al., 2006). The phenomenon of relapse is so
common that it can be considered a core characteristic of the alcoholic state.
1.2. Concept of chronic alcohol adaptation—the kindling/allostasis hypothesis
Since alcoholism is characterized by persistence of excessive alcohol intake (Beigleiter,
1975), concepts were proposed to understand how initiation of alcohol use might lead to
alcoholism. While development of tolerance during chronic alcohol exposure had long been
recognized, the possible relationship between adaptive change and maintenance of excessive
alcohol use in the alcoholic was overlooked. A critical observation concerning the
consequence of prolonged excessive alcohol use to adaptation came from a report to
understand why only a small percentage of alcoholics exhibited seizure activity during
abstinence from alcohol (i.e. during alcohol withdrawal). In this seminal report, Ballenger
and Post (1978) hypothesized that a kindling-like cumulative adaptive process occurs in
brain over time with excessive chronic alcohol exposure, an adaptation which ultimately
results in seizure production (“epilepsy”) during cessation of alcohol intake (withdrawal).
Subsequent assessments in alcoholics were consistent with this hypothesis (Booth and Blow,
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1993; Lechtenberg and Worner, 1991). “Kindling” is a term defined as a change in brain
physiology caused by repeated subthreshold levels of electrical stimulation until
epileptiform activity results in seizure activity to a subthreshold stimulus. Importantly, this
cumulative kindling process that increases the sensitivity to stimulus-induced seizure
activity is relatively permanent. In critical support of repeated alcohol exposures and
withdrawals being capable of producing this persistent change in CNS function, evidence in
animals subsequently showed that withdrawals from repeated alcohol exposures could
indeed facilitate kindling of seizure activity (McCown and Breese, 1990). In addition to
proposing that a cumulative adaptive change was responsible for withdrawal-induced
seizures in alcoholics, Ballenger and Post (1978) also noted that symptoms other than
seizures worsened during withdrawal in alcoholic patients over the extended course of
alcohol abuse. Based upon these findings, these investigators further contended that if a
‘kindling-like’ process occurs with excessive alcohol use, alcoholism would truly be a
cumulative illness by which continued drinking adds to‘ previous drinking which overtime
worsens the overall withdrawal syndrome.
The role of persisting adaptive consequences of chronic brain alcohol exposure being a
contributor to alcoholism was not immediately embraced. However, some two decades later,
the Koob laboratory (Koob, 2003; Koob and LeMoal, 1997; 2001; Roberts et al., 2000)
proposed that prolonged excessive alcohol exposure produced an “allostatic change” in brain
function to explain the characteristic components of alcoholism, particularly the symptoms
of withdrawal. Allostasis, as a term, is stated to be an adaptive process of achieving
functional stability by a physiological adjustment outside of normal homeostasis (McEwen,
2000; McEwen and Wingfield, 2003). Subsequently, Overstreet et al. (2002) found that
intermittent exposures to chronic alcohol sensitized alcohol withdrawal anxiety, a change
attributed to a “kindling-like” adaptive process (see Section 2). Regardless of whether one
refers to the adaptive consequence of repeated exposures to excessive alcohol exposure as a
“kindling”-like process (Ballenger and Post, 1978; Breese et al., 2005c; McCown and
Breese, 1990) or to an increased “allostatic load” (Koob, 2003; Koob and LeMoal, 2001;
Roberts et al. 2000), the hypothesized persistence of adaptation induced by alcohol is
proposed to be responsible for the accentuated neurobiological sequalae observed in
alcoholics upon cessation of alcohol drinking (Breese et al., 2005c; Koob, 2003). In fact, the
worsening negative emotion that predominates during alcohol abstinence in the alcoholic is
proposed to result in continued alcohol use to overcome the enhanced negative symptoms
associated with withdrawal (Breese et al., 2005c; Heilig and Koob, 2007; Heilig et al.,
2010ab; Koob, 2008, 2009; Koob and LeMoal, 2005, 2008).
An additional point to be addressed is that repeated chronic alcohol exposures result in
escalation of voluntary alcohol intake, measured either as simple two-bottle free-choice
drinking or operant self-administration. This phenomenon is observed transiently following
repeated periods of alcohol availability and deprivation [alcohol deprivation effect (ADE);
Sinclair and Senter, 1968] or following repeated cycles of experimenter-imposed
intoxication and withdrawal (O’Dell et al., 2004; Roberts et al, 2000; Sommer et al., 2008;
Valdez et al., 2002, 2003, 2004). In respect to adaptation by chronic alcohol influencing
alcohol intake, work showed that prolonged brain exposure to intermittent cycles of alcohol
intoxication results in up-regulation of voluntary alcohol intake that persists long after acute
withdrawal symptoms subside (Roberts et al., 2000; Valdez et al., 2002, 2004; See Section
3). This reflection of excessive drinking that occurs in animals may be comparable to the
loss of control (i.e., excessive alcohol intake) observed in drinking alcoholics and in
abstinent alcoholics during relapse (Keller, 1972).
After a period of time from excessive alcohol drinking, the alcoholic becomes free of the
acute withdrawal symptoms. Nonetheless, an often quoted statement is “once an alcoholic
BREESE et al. Page 4













always an alcoholic”. While the excessive relapse rate of abstinent alcohol dependent
individuals would be consistent with this latter view (Fein and Landman, 2005), a
neurobiological basis for this unfortunate consequence in the alcoholic remained elusive. In
recent years, progress to understand the susceptibility of alcoholics for relapse provided an
outcome that supports the brain of alcoholics being distinct from normal individuals (Fox et
al., 2007; Gilman and Hommer, 2008; Sinha, 2001, 2008a; Sinha and O’Malley, 1999; Sinha
et al., 2009, 2010) Consequently, this distinction in the alcoholic brain could be responsible
for the dysfunctional behavioral and altered functional responses in alcoholics not observed
in social drinkers (see details in Sections 5 & 6).
The purpose of this overview is to provide evidence that chronic alcohol induces a persistent
cumulative adaptation that alters brain function by a kindling/allostatic process—a change
that facilitates the many negative attributes associated with alcoholism. Section 2 provides
evidence that repeated cycling of alcohol induces this kindling/allostatic process of
cumulative adaptation more effectively than does continuous alcohol. Section 3 reviews
material concerning models of alcohol intake. In Section 4, material is provided that stress
after the cumulative adaptation induced by chronic intermittent alcohol exposure induces an
increased negative behavioral responsiveness and enhanced alcohol self-administration
(Breese et al., 2004; Valdez et al. 2003; Sommer et al. 2008). These latter observations are
consistent with evidence presented in Section 5 that the abstinent alcoholic is more
susceptible to induction of negative emotional state by “stresses” and alcohol cues (Gilman
and Hommer, 2008; Sinha 2001, 2007, 2008ab; Sinha et al., 2009, 2010). Another point
emphasized in Section 5 is that the negative response in the alcoholic to stress and alcohol
cues is accompanied by increased craving—a response which may be associated with the
heightened likelihood of relapse (Sinha, 2001, 2008; Sinha and Li, 2007; Sinha et al., 2009,
2010). Section 6 will provide evidence from measurements of functional brain imaging that
stress and alcohol-cues result in altered brain activity which differentiates the alcoholic from
controls. This latter section will also emphasize how testing of drugs on brain imaging
changes to stress and alcohol cues in alcoholics could provide a new strategy for identifying
promising therapies for this disorder.
For each of these critical issues, available information which has evolved to understand the
neurobiological basis of alcohol adaptation within specific brain sites will be provided. By
understanding the biological and neuroanatomical factors that contribute to the cumulative
adaptation associated with excessive drinking, avenues for future treatment may be possible
that will minimize the vulnerability alcoholics have for relapse to excessive alcohol use.
Identification of the progress made thus far provides optimism for a favorable future outlook
for addressing alcoholism as a disease.
2. Neuroadaptation by Repeated Alcohol Cycling: Evidence for the
Kindling/Allostasis Hypothesis
2.1. Repeated cycling of chronic alcohol induces a persistent adaptation
As noted earlier, Ballenger and Post (1978) implied that excessive alcohol ingestion over
years induces an adaptation that accentuates detrimental consequences during repeated
removals from alcohol. Similar in concept to the “alcohol kindling hypothesis” (Ballenger
and Post, 1978), Koob and LeMoal (2001) later proposed that repeated alcohol exposures
result in a cumulative adaptation that accentuates the negative consequences observed
during alcohol withdrawal—an adaptation related to a change in “allostatic load” (McEwen,
2000). However, while an intermittent exposure to alcohol was a requirement for “kindling”
of seizures (Becker and Hale, 1993; McCown and Breese, 1990; Ulrichsen et al., 1995,
1998ab), critical investigations had not been performed to establish whether intermittent
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chronic cycles of alcohol were essential for enhancement of the anxiety and negative mood
observed during alcohol removal.
A strategy of repeated cycling of alcohol exposure similar to that used to evaluate kindling
of seizures was utilized to test if intermittent alcohol exposure was indeed required for
induction of adaptation that resulted in negative emotional symptoms during withdrawal
from alcohol. As illustrated in Figure 1, rats exposed to only 3 cycles of 5 days of 4.5%
alcohol diet interrupted by two days of abstinence exhibited sensitization of anxiety-like
behavior 5–6 hrs after removal of the final cycle of alcohol (Overstreet et al., 2002). This
sensitization occurred equally in both male and female rats (Overstreet et al, 2004b).
Importantly, removal of alcohol from rats that received the same amount of alcohol
continuously did not induce negative symptoms upon alcohol removal. These findings
indicate that cycling of alcohol exposure is a critical contributor to the adaptation that
supports sensitization of anxiety during alcohol withdrawal, a process proposed to be
comparable to that by which repeated alcohol cycling kindles seizures (McCown and
Breese, 1990). Nonetheless, it is apparent that a considerably shorter period of alcohol
cycling is required to sensitize an emotional response during withdrawal (Overstreet et al.,
2002) than is needed to induce “kindling” of seizures (McCown and Breese, 1990). Similar
conclusions concerning adaptation have been expressed using other means of brain alcohol
exposure and readouts of negative emotionality (Gilpin et al., 2008ab;O’Dell et al.,
2004;Rimondini et al. 2002;Roberts et al. 2000;Sommer et al., 2008;Valdez et al., et al.
2002,2004). These observations are consistent with the interpretation by Ballenger and Post
(1978) that symptoms of alcohol withdrawal with alcohol abuse worsen over the course of
time.
Consistent with extended alcohol use resulting in a persistent adaptation, the Begleiter
laboratory documented in rats as well as in male alcoholics that chronic alcohol dependence
was associated with an extended increase in brain activity after withdrawal from alcohol
(Begleiter and Porjesz, 1977; Porjesz and Begleiter, 1981). Later, Roberts et al. (2000)
demonstrated that alcohol self-administration was elevated for 4–8 weeks after alcohol
dependent rats were withdrawn from initial exposure. Based upon this finding, protracted
withdrawal symptoms from chronic alcohol were proposed to be capable of triggering
relapse. More recently, the repeated cycling of chronic alcohol in rats was also discovered to
induce a persisting adaptation (Overstreet et al., 2002). Evidence for this persistence was
demonstrated by observing sensitization of withdrawal-induced anxiety-like behavior
following re-exposure to a single 5 days of alcohol diet 16 days following previous exposure
to repeated cycles of alcohol (Figure 2). Removal from a single 5-day period of alcohol diet
of animals not previously exposed to alcohol diet produced no anxiety-like behavior
(Overstreet et al., 2002). Consistent with this report, intermittent alcohol exposures were
later reported to produce an extension of the expression of alcohol withdrawal symptoms
(Zhang et al., 2007). Likewise, Sommer et al. (2008) demonstrated fear suppression of
behavior after an extended absence from intermittent alcohol exposure. Rimondini et al.
(2008) found a long-lasting tolerance to alcohol following induction of dependence—an
additional demonstration of a persistence of adaptation following chronic alcohol exposure.
In Section 3, it will be demonstrated that previous extended intermittent exposure to alcohol
produces an escalation of voluntary alcohol intake (Rimondini et al. 2002, 2003; O’Dell et
al., 2004; Valdez et al., 2002, 2004). Collectively, these findings indicate that the outcome
of continuing alcohol use results in neural alterations that persist beyond acute withdrawal.
Such persistent functional changes induced by intermittent alcohol exposure are
accompanied by equally persistent changes in brain gene expression patterns (McBride et
al., 2009; Rimondini et al., 2002; Sommer et al., 2008). The importance of this extended
adaptation in the susceptibility alcoholics have to stress is outlined in Sections 4 & 5.
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Consequently, efforts over several decades (Ballenger and Post, 1978; Koob and LeMoal,
2001; McCown and Breese, 1990) have provided seminal support for the postulated concept
that intermittent chronic alcohol exposures are capable of producing a persisting adaptation.
Subsequently, to minimize the progressive increase in withdrawal symptoms to the
intermittent alcohol exposures an escalation of alcohol drinking occurs—a circumstance that
ultimately leads to addiction (Breese et al., 2005ac; Heilig and Koob 2007; Heilig et al.,
2010ab; Koob, 2009). Importantly, documenting that intermittent alcohol exposures induce a
persistent adaptation provided an excellent means by which to document whether a
“cumulative adaptive process” is responsible for the intermittent alcohol exposures
facilitating alcohol withdrawal symptoms.
2.2. Neuroadaptation induced by intermittent alcohol cycling facilitates alcohol withdrawal
anxiety: Documentation of a cumulative adaptive process
In spite of the cumulative adaptation hypothesis being an attractive explanation for removal
from intermittent alcohol treatments sensitizing withdrawal symptoms (Ballenger and Post,
1978; Koob, 2003; McCown and Breese, 1990), this interpretation had not been critically
tested. Therefore, to confirm the hypothesis that the adaptation induced by the intermittent
alcohol exposure was cumulative, it was reasoned that if drug treatments were given during
withdrawal from the 1st and 2nd alcohol cycles of the repeated cycle protocol, sensitization
of anxiety-like behavior would not be observed during withdrawal from the 3rd and final
alcohol cycle. Since the benzodiazepine (BZD) diazepam was known to prevent withdrawal
anxiety (Knapp et al, 2004), this BZD was administered during the initial two ethanol
withdrawals. Consistent with a cumulative adaptation being responsible for the withdrawal-
induced anxiety induced by the repeated alcohol exposures, the diazepam prevented the
ethanol withdrawal anxiety (Knapp et al., 2005). Additional results implicating GABA
function in the withdrawal sensitization was that the GABAB agonist, baclofen,
administered during early withdrawals also prevented the adaptation that supports
facilitation of withdrawal-induced anxiety-like behavior induced by the repeated alcohol
cycling protocol (Knapp et al., 2007a). Paradoxically, flumazenil, a BZD receptor
antagonist, administered during the initial withdrawals was also capable of blocking
sensitization of withdrawal anxiety (Knapp et al., 2005). Likewise, buspirone, a 5-HT1A
receptor agonist as well as a 5-HT2C receptor antagonist preventing sensitization of
withdrawal-induced anxiety implicated altered serotonergic function in the sensitization
(Overstreet et al., 2003, 2005). Importantly, a CRF1-receptor (CRF1R) antagonist also
prevented the intermittent alcohol exposure adaptation responsible for sensitization of
withdrawal-induced anxiety (Overstreet et al., 2004a, 2005). This action by the CRF1R
antagonist was consistent with alcohol-induced neuroadaptation resulting in recruitment of
CRF transmission. See Section 4.1 for changes in CRF measures by stress and chronic
alcohol exposure.
Finding that selected drugs given during initial ethanol withdrawals prevent sensitization of
alcohol withdrawal anxiety (Knapp et al., 2007a; Overstreet et al., 2003, 2004a, 2005)
provided critical support for the Ballenger and Post (1978) and Koob (2003) postulate that
the adaptation that occurs with the repeated alcohol exposures is indeed cumulative.
Additionally elucidated was that the drug treatments given during the initial removals from
alcohol cycling, which prevented the initial sensitization of withdrawal anxiety, also
prevented sensitization of anxiety during withdrawal from a later re-exposure to a final cycle
of alcohol diet—a reflection that the ethanol cumulative adaptation associated with the
initial intermittent alcohol cycles persists (Breese et al., 2004; 2008; see Section 4). The fact
that distinct drug classes block sensitization of alcohol-withdrawal anxiety-like behavior as
well as the persistent adaptation by the multiple cycles of alcohol clearly implicates differing
neural pathway involvement in the adaptive process induced by alcohol. However, while
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this observation is informative, yet to be resolved is the basis by which altering each of these
several neural pathways individually prevents the adaptation responsible for sensitization of
withdrawal symptoms and the persistence of adaptation by the repeated alcohol cycling.
2.3. Neuroanatomical sites support the cumulative adaptation Induced by intermittent
alcohol cycling
Microinjection of drugs into specific brain sites were used previously to identify regions
critical for their action to effect withdrawal seizures (Frye et al., 1983), alcohol sedation
(Breese et al., 1984; Givens and Breese, 1990; McCown et al. 1985; 1986) as well as the
anxiety that accompanies withdrawal from chronic alcohol exposure (Rassnick et al., 1993).
With knowledge that specific pharmacological compounds prevent the cumulative
adaptation induced by repeated cycling of chronic alcohol (Section 2.2), these drugs were
microinjected into appropriate brain sites during the 1st and 2nd withdrawals, but not the
final withdrawal of the protocol, to identify brain regions associated with the adaptation
induced by repeated alcohol cycling. From this exploration to define specific sites of action
of these drugs, it was hoped that some clarification would occur to resolved how differing
neurotransmitter systems were capable of preventing sensitization of anxiety that follows
withdrawal from the repeated alcohol cycling (Section 2.2).
Using the microinjection strategy outlined, Figure 3 provides examples of the site selectivity
within the dorsal raphe and amygdala of drugs affecting differing 5-HT receptors as well as
the site selectivity observed with flumazenil. When the 5-HT1A receptor (5-HT1AR) agonist
was microinjected into the dorsal raphe (DRN), sensitization of withdrawal anxiety was
prevented (Overstreet et al., 2006). However, microinjection of the 5-HT1AR agonist into
the central amygdala (CeA) during the initial withdrawals was ineffective in preventing
sensitization. In contrast to the 5-HT1AR agonist, microinjection of the 5-HT2CR antagonist
into the CeA prevented the anxiety-like behavior induced during withdrawal from the
repeated alcohol cycles, but was ineffective when administered into the DRN (Overstreet et
al., 2006). Importantly, a 5-HT2CR agonist microinjected into the CeA prior to a single 5
days of alcohol diet induced sensitization of alcohol-withdrawal anxiety (Overstreet et al.,
2006). Further shown in Figure 3 is that flumazenil microinjected into the CeA during early
withdrawals blocked the sensitization of anxiety observed during the final alcohol
withdrawal without producing this inhibition after administration into the DRN (Knapp et
al., 2007b). These various drug exposures had no effect on sensitization of withdrawal
symptoms when administered into the paraventricular nucleus (PVN) or the nucleus
accumbens (NAC) (Knapp et al., 2007b). Importantly, the brain regions identified to
influence withdrawal-induced anxiety have previously been found to be critical for support
of anxiety-like behavior (Koob, 2008;Koob and LeMoal, 2005,2008; Shin and Liberzon,
2009; Wand, 2005). In Section 4, the brain sites at which CRF1R antagonists influence
sensitization of negative symptoms associated with alcohol withdrawal is discussed in
relation to the role of CRF in stress-induced adaptive change (Breese et al., 2004).
An important conclusion from defining sites of action of drugs during intermittent alcohol
exposure is that neurotransmitter systems in differing brain regions are capable of
supporting the cumulative adaptation responsible for sensitization of emotional behavior
during withdrawal from the repeated alcohol cycling. Notable from the drug microinjections
into active sites was that the sensitized alcohol withdrawal response returned to the
normality observed in control rats, just as seen after systemic administration of these agents
(Section 2.2). While not resolving the basis of differing brain sites inducing a near complete
blockade of the cumulative adaptive expression of withdrawal symptoms associated with the
repeated cycling of alcohol, a logical conclusion could be that a neural system identified
within a given brain site is in series with other sites involved in the negative symptoms
observed during withdrawal from alcohol. Therefore, disruption of neurotransmitter
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signaling at any site associated with the proposed serial organization of differing neural
pathways could prevent the exaggerated behavioral responses during withdrawal. Even
though this hypothesis of an integrated circuit involving differing neural systems may
support the adaptation induced by repeated alcohol exposures, no direct empirical support
exists for this hypothesis, but it is certainly a view that should be tested.
3. Alcohol intake and relapse-like behavior
3.1. Reinstatement of operant responding as a model of alcohol seeking
An increasingly popular approach allows modeling of the motivational aspect of relapse-like
behavior in the absence of drug. In this protocol, stable operant responding for alcohol is
established followed by continued daily operant sessions in which the alcohol re-
enforcement is absent. This absence will lead to extinction of responding on the previously
alcohol-delivering lever over the course of 2–3 weeks (Mellow and Mendelson, 1964;
Samson, 1986). However, following extinction from alcohol, categories of stimuli known to
be potent relapse triggers in human alcoholics are able to produce a robust resumption or
“reinstatement” of responding on the previously alcohol-associated lever in the absence of
alcohol reinforcement. Reinstatement will occur with a priming dose of alcohol, an “alcohol
cue”, exposure to inescapable shock, or to nicotine (see discussion in Section 4) (Lê et al.,
1998, 2003; Lê and Shaham 2002). Using this model of alcohol seeking, preclinical studies
have identified CRFR antagonists, α2-adrenergic agonists, α1-noradrenergic antagonist,
dopamine receptor antagonists, and selected glutamatergic agents that reduce responding
when given prior to initiation of a session (Besheer et al. 2006; Gehlert et al., 2007; Lê et al.,
2005; Liu and Weiss, 2002ab; Mantsch et al., 2008; Marinelli et al., 2007; Rasmussen et al.,
2008; Shaham and Hope., 2005; Walker et al., 2008; Zhao et al., 2006). Investigations that
explored drug treatments on reinstatement of alcohol seeking after extinction have been
summarized in reviews (Heilig and Egli, 2006; Koob and LeMoal, 2008; Sanchis-Segura
and Spanagel, 2006; Sinclair, 2001; Spanagel, 2009; Weiss, 2005). In respect to sites of
action supporting responding, Lê et al. (2002) reported that a 5HT1A receptor agonist and
CRF into the raphe nucleus reinstated alcohol seeking. Additionally, Chaudhri et al. (2009)
reported differing roles for the core and shell of the NAC in context and cue-induced alcohol
seeking.
3.2. Escalation of voluntary alcohol drinking and operant self-administration
Another question key to the concept of “kindling” of cumulative neuroadaptation by alcohol
is whether such previous adaptation can increase the motivation to escalate either simple
voluntary two-bottle free-choice drinking or operant self-administration, just as this
adaptation supports emotional responses during withdrawal. Noteworthy is that the two
approaches of assessing drinking may at times produce diverging results due to potential
contributions of taste and appetite for calories in the simpler model. However, since
neuroadaptation by these approaches consistently escalates alcohol drinking (see Heilig and
Koob, 2007), they are presented together. The relationship between alcohol dependence,
experience with withdrawal, and subsequent alcohol self-administration has been the subject
of extensive research. Early studies generally yielded equivocal findings (Begleiter, 1975;
Deutsch and Koopmans 1973; Hunter et al., 1974; Myers et al., 1972; Numan, 1981;
Samson and Falk, 1974; Schulteis et al., 1996; Winger, 1988). This outcome was most likely
because procedures did not sufficiently establish the reinforcing effects of alcohol prior to
dependence induction. In these situations, minimal opportunity likely occurred to allow an
association of alcohol drinking with its alleviation of withdrawal consequences (Meisch,
1983; Meisch and Stewart, 1994). Taking this into account, more recent studies in mice
(Becker and Lopez 2004; Chu et al., 2007; Dhaher et al., 2008; Finn et al., 2007; Lopez and
Becker, 2005) and rats (Funk et al., 2006b, 2007; Gilpin et al., 2008ab; O’Dell et al., 2004;
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Rimondini et al. 2002; Roberts et al. 2000; Sommer et al. 2008; Valdez et al., 2002) have
demonstrated “escalated” operant self-administration or increased free-choice drinking of
alcohol in animals with a history of dependence compared to those without such a history. In
agreement with a “kindling” process by alcohol exposure being responsible for the increase
in drinking, repeated ethanol withdrawal (deprivation) experiences are more potent in
inducing escalation than is continuous alcohol exposure (O’Dell et al., 2004; Rodd et al.,
2003). Further, this consequence of alcohol dependence was shown to induce an extended
peristence of self-administration (Gilpin et al., 2008a; Rimondini et al. 2002; Roberts et al.
2000; Sommer et al., 2008; Valdez et al., 2002).
Importantly, post-alcohol dependent self-administration can have a different pharmacology
from that of baseline alcohol self-administration. For example, CRF1R antagonists blocked
the increase in alcohol consumption in dependent animals without having an effect on intake
in non-dependent rats (Funk et al., 2007; Gehlert et al., 2007; Gilpin et al., 2008b). Similar
to CRFR1 antagonist action, a kappa-opioid antagonist, as well as acamprosate, selectively
suppressed alcohol self-administration in dependent rats, but both had no consequence in
non-dependent rats (Rimondini et al., 2002; Walker et al. 2008; Walker and Koob, 2008).
Additionally, Rimondini et al. (2005) demonstrated that administration of the neuropeptide
Y (NPY) type2 receptor antagonist to facilitate NPY release suppressed alcohol responding
in dependent rats while being without effect on self-administration in non-dependent rats.
The results with the CRF1 and NPY2 receptor antagonists are in accord with the belief that
NPY and CRF exert a reciprocal regulation (Heilig et al., 1994; Sajdyk et al. 2006; Valdez
and Koob, 2004). The involvement of CRF and NPY on alcohol drinking has been reviewed
(Ciccocioppi et al., 2009).
Limited studies have been performed to identify sites at which drugs act to influence alcohol
self-administration in animals. For example, in the absence of physical dependence, there is
body of literature implicating GABA and nicotine receptors in the NAC in alcohol drinking
(e.g., Nadal et al., 1998; Rewal et al., 2009). Additionally, Besheer et al. (2010) found that
metabotropic-glutamate (mGLU)-5R activity in the NAC was required for maintenance of
alcohol self-administration. Just as noted for the distinct effects of a CRFR antagonist in
post-dependent and non-dependent animals on alcohol consumption, microinjection of a
general CRF antagonist (D-Phe CRF12–41) into the CeA prevented alcohol self-
administration in alcohol-dependent rats, while being without an effect on this measure in
non-dependent rats (Funk et al., 2006b). Administration of this general CRFR antagonist
into the lateral dBNST and the NAC did not alter responding for alcohol in either the
alcohol-dependent or non-dependent rats. Collectively, these findings indicate that the
elevation of alcohol self administration in dependent rats is associate only with specific
regions of brain (Funk et al., 2006b). In contrast to CRF involvement in the support of
alcohol self-administration in dependent rats, urocortin 3, an agonist for the CRF2R, injected
intraventricularly (Valdez et al., 2004) or into the CeA (Funk and Koob, 2007) was capable
of preventing alcohol self-administration in dependent rats, while increasing intake in non-
dependent rats. This finding is consistent with CRF2Rs having an apposing action to
CRF1Rs, which are clearly responsible for the elevated alcohol self administration in
dependent rats. By defining neuroanatomical sites related to drugs that affect this excessive
drinking in dependent rats, it will be possible to identify at a cellular level the
neurobiological basis of the cumulative adaptation induced by the chronic alcohol exposure
that facilitates alcohol drinking—a strategy that should be encouraged.
3.3. The alcohol deprivation effect (ADE) as a model of relapse-like drinking
Abstinent alcoholics are known to drink excessive amounts of alcohol upon relapse, a
reflection of “loss of control”. An excess of alcohol drinking in animals after repeated
intermittent chronic alcohol exposures was first described by Sinclair and Senter (1968) as
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an alcohol deprivation effect (ADE)—a phenomenon proposed as an animal model of the
loss of control observed during relapse (Spanagel and Holter 2000). Wolffgram and Heyne
(1995) demonstrated that the excessive drinking induced by the ADE protocol persisted for
an extended period after the initial repeated alcohol drinking episodes. Other reports
demonstrated that intermittent voluntary alcohol drinking produced a persisting consequence
on ADE in a high alcohol drinking-1 (HAD1) rat line (Rodd-Henricks et al., 2000a) as well
as in the alcohol preferring P-rat strain (Gilpin et al., 2008ab; Rodd-Henricks et al., 2000b;
Toalston et al., 2008). Repeated deprivations following an initial period of free access have
recently also been shown to result in progressive escalation of alcohol drinking in C57BL/6
mice (Melendez et al., 2006). It is important to recognize that the excess drinking observed
with the ADE protocol may not be equivalent to the excess drinking observed with the
change observed with ethanol dependence discussed in Section 3.2.
Repeated (intermittent) cycling of alcohol drinking in the P-rat strain was recently shown to
facilitate the ADE phenomenon within a short time period (Breese et al., 2004; Overstreet et
al., 2007; see Figure 8). A reasonable assumption for repeated chronic alcohol exposures
being required for the ADE is that the exposure to the repeated cycling of alcohol induces a
cumulative adaptation which accentuates the loss of control to limit alcohol intake upon re-
exposure to alcohol. Drugs have been tested during the final drinking cycle to determine
what neural mechanisms would affect the excessive alcohol ingestion in this ADE model.
Opiate antagonists minimize this excessive alcohol intake implicating a possible
involvement of an opiate mechanism in this aspect of alcohol dependence (Altschuler et al.,
1980; Hölter and Spanagel, 1999; Hubbel et al., 1986; Sinclair 1990). Subsequently, these
early preclinical observations led to finding that this opiate antagonist was useful in
minimizing the loss of control characteristic of the alcoholic during a relapse episode
(O’Malley et al., 1992; Vollpicilli et al., 1992; See reviews by Bouza et al., 2004; Heilig and
Egli, 2006; Sinclair, 2001; Soyka and Roosner, 2008). Likewise, the action of acamprosate
to reduce excess alcohol drinking in the ADE protocol supported its clinical use in treatment
of alcohol dependence (see review by Bouza et al., 2004; Heilig and Egli, 2006; Spanagel,
2009).
This induction of a rapid facilitation of ADE induced by repeated intermittent cycling of
voluntary alcohol intake in P-rats (Breese et al., 2004) could provide a convenient approach
to investigate whether an underlying cumulative adaptation associated with repeated
deprivations indeed supports the progressive increase in alcohol drinking. In this respect,
Roberto et al. (2010) showed that chronic repeated administration of a CRF-1 antagonist
protocol blocks development of excess alcohol intake associated with an ADE in
nondependent rats and prevents withdrawal-induced excessive drinking in dependent rats.
Certainly, future studies are encouraged to fully understand the neural basis of the
cumulative increase in the excessive voluntary alcohol drinking induced by the ADE. In
Section 4.4, stress induction of a cumulative adaptation during repeated cycles of voluntary
drinking will be shown to facilitate the ADE.
4. Stress Interacts with Chronic Alcohol Neuroadaptation
4.1. Repeated Stresses accentuate the maladaptation induced by chronic alcohol
Introductory remarks (Section 1.1) provided logic for stress involvement in alcoholism.
Previous reports have supported CRF being a primary central mediator of stress (Bale and
Vale, 2004; Dunn and Berridge, 1990; Imaki et al., 1993; Koob and Heinrichs, 1999; Vale et
al., 1981). In confirmation of CRF involvement with chronic alcohol and stress exposure,
Merlo-Pich et al. (1995) using dialysis found an increase in extracellular CRF levels in the
amygdala of rats during restraint stress and after alcohol withdrawal. Likewise, Cook (2004)
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reported that sheep exposed to an acute predator (i.e., a stress) increased CRF release from
the PVN and the amygdala.
Given the earlier observation that a CRF1R antagonist prevented the cumulative adaptation
induced by repeated cycling of alcohol (Section 2.2; Overstreet et al., 2004a), there was an
impetus to explore whether stress would substitute for initial withdrawals of the repeated
alcohol protocol to sensitize withdrawal symptoms following a single alcohol cycle.
Subsequently, Breese et al. (2004) found that restraint stress applied at weekly intervals
prior to only 5-days of alcohol diet (i.e., the stress/alcohol withdrawal protocol) did indeed
sensitize anxiety-like behavior during removal from the alcohol exposure (Figure 4).
Likewise, sensitization of anxiety was not seen with just weekly stress application (i.e. no
alcohol diet) or upon withdrawal from only 5-days of chronic alcohol exposure (i.e. no
stress; Figure 4). Consequently, this investigation (Breese et al., 2004) demonstrates that
repeated exposures to restraint stress is capable of inducing an adaptation that allows a lesser
amount of alcohol to sensitize negative symptoms during withdrawal that would not
otherwise be observed. At this time, the many types of stress noted by Nestler et al. (2002)
have not been tested prior to ethanol to determine if all will facilitate ethanol adaptation.
Additionally important was demonstrating that the systemic corticosterone increase induced
by the repeated stress exposure was not responsible for the stress-induced sensitization of
alcohol withdrawal-induced anxiety (Breese et al., 2004). This latter finding provided strong
evidence that activation of neural pathways distinct from the hypothalamic-pituitary-adrenal
(HPA) axis path is critical for the stress-induced behavioral sensitization during alcohol
withdrawal (Breese et al., 2004). This latter conclusion is in agreement with other
observations that extrahypothalamic neural systems linked to stress, rather than the
hypothalamic-pituitary pathway, are involved in neuroadaptive mechanisms that influence
ethanol actions (Gehlert et al. 2007; Lê et al. 2000; Lowery et al., 2010). A final critical
observation concerning the adaptation induced by the repeated stress/alcohol withdrawal
protocol was that re-exposure to an additional 5 days of alcohol diet 16 days after alcohol
removal from the original protocol resulted in sensitization of anxiety during withdrawal
from this later alcohol exposure (Breese et al., 2004). Animals re-exposed to a 5-day alcohol
challenge that received only control diet did not display an alteration in behavior during
withdrawal (Breese et al., 2004). This latter finding is compatible with the stress/alcohol
withdrawal protocol supporting a persistent adaptation (Breese et al., 2004), just as observed
with repeated cycles of chronic alcohol (Section 2.1). Collectively, stress-induced
facilitation of alcohol action supports the view that stress induces a “kindling process” or an
allostatic adaptive state (Korte et al., 2005) that facilitates a detrimental consequence during
withdrawal from only 5 days of alcohol exposure. Documentation is presented in Section
4.2 that a cumulative adaptation is the means by which repeated stress facilitates alcohol
adaptation.
As noted in our introductory remarks (Section 1.2), human studies have demonstrated that
alcoholic patients exhibit an increased susceptibility to stress not observed in social drinking
controls (Gilman and Hommer, 2008; Gilman et al., 2008; Sinha, 2001). In accord with
these clinical studies, a preclinical investigation demonstrated that stress 3 days after
exposure to cycling of chronic alcohol induced an anxiety-like response that was not
observed when stress was applied to animals not previously exposed to alcohol (Breese et
al., 2005b). Noteworthy is that others have also shown that chronic alcohol exposure
enhances the consequences of stress (Liu and Weiss, 2003; Sommer et al. 2008; Valdez et
al. 2003). Thus, such enhancement of stress symptoms in previously chronic alcohol-
exposed animals is felt to be comparable to the increased susceptibility abstinent alcoholics
have to stressful imagery (Sinha, 2001; See Section 5.1 for clinical details). In line with
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stress interacting with alcohol, Section 4.4b documents that stress during repeated cycles of
alcohol escalates alcohol self-administration (Breese et al., 2004; Sommer et al. 2008).
Based upon both basic and clinical findings, a conclusion is that stress can produce a
negative outcome associated with chronic alcohol exposure irrespective of whether the stress
occurs before or after alcohol exposure. To account for the escalating negative behavioral
pathology associated with stress during abstinence in the alcoholic, the “kindling”/stress
hypothesis of alcoholism was proposed (Breese et al., 2005c). Therefore, this documentation
that stress influences the pharmacology of alcohol provides a compelling rationale for
continuing to clarify the basis of the neuroadaptive processes that accompany stress
interactions with alcohol.
4.2. Documentation of a cumulative adaptive process in facilitation of alcohol adaptation
by stress: Neural mechanisms involved
Based upon CRF involvement in the action of stress (Vale et al., 1981), it was reasoned that
CRF was a plausible mediator in the stress facilitation of alcohol adaptation. In support of
this view, Figure 5 shows that systemic administration of a CRF1R antagonist prior to the
weekly stresses (i.e., the stress/alcohol withdrawal protocol) prevented sensitization of
anxiety during alcohol withdrawal (Breese et al., 2004). As noted earlier for repeated
cycling of alcohol (Section 2.2), the strategy of administering the CRF1R antagonist prior to
the early repeated stresses, but not during the final withdrawal from alcohol, clearly
indicates that the repeated stresses induce a cumulative adaptive process that is essential for
facilitation of alcohol withdrawal symptoms (Figure 5). In addition, a CRF1R antagonist
given during the initial cycles of the repeated withdrawal protocol prevented the later stress-
induced anxiety (Breese et al., 2005b) indicative that the cumulative adaptation induced by
the repeated alcohol exposures support this accentuated response to the stress challenge. In
further confirmation of CRF importance to the cumulative adaptation responsible for
sensitization of alcohol withdrawal anxiety by stress, CRF given repeatedly
intracerebroventricularly (ICV) prior to a single 5-day alcohol exposure sensitized
withdrawal-induced anxiety-like behavior that was prevented by a CRF1R antagonist
(Overstreet et al., 2004a). Collectively, these findings support the conclusion that CRF
mediation should be a critical focus of treatment for preventing negative symptoms and
other consequences induced by withdrawal from chronic alcohol and by stress (Breese et al.,
2005b; Gehlert et al., 2007; Heilig and Koob, 2007; Zorrilla and Koob, 2004).
In confirmation of CRF association with a history of alcohol dependence, a prolonged
history of alcohol exposure induced a persistent up regulation of post-synaptic CRF1R
expression and increased levels of CRF in brain for extended periods after alcohol removal
(Roberto et al., 2010; Sommer et al., 2008; Zorrilla et al., 2001; Weiss et al., 2001).
Conversely, the CRF2R, which in many circumstances has actions opposite to those of the
CRF1 subtype (Valdez et al., 2004; Funk and Koob, 2007), was down-regulated within the
amygdala complex following an extended period of ethanol withdrawal (Sommer et al.
2008). However, upon acute withdrawal from chronic intermittent exposure to alcohol
vapor, Martin-Fardon et al. (2010) observed reduced CRF1R, but not CRF2R, binding in the
CeA, medial amygdala, and the basolateral amygdala of Wistar rats. This latter reduction in
CRF1R binding observed shortly after ethanol removal could be attributed to internalization
of the CRF1R by the elevated CRF presence during ethanol exposure and withdrawal
(Martin-Fardon et al., 2010; Olive et al., 2002; Weiss et al., 2001). However, upon extended
ethanol withdrawal, this process must be reversed resulting in an increase in CRF1Rs, as
noted by Roberto et al. (2010). See Section 4.4c for further modifications in CRF function
by stress and alcohol.
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Since drugs not directly associated with CRFR function prevented the ethanol adaptation
induced by the repeated cycling of alcohol (See Section 2.3; Figure 3), studies of other
drugs were undertaken to define if neural mechanisms other than CRF seen with adaptation
by the repeated cycling of alcohol were involved in stress sensitization of alcohol
withdrawal anxiety. As shown in Figure 5 both flumazenil and a 5-HT1A receptor agonist
(buspirone) given prior to each of the stresses also prevented sensitization of ethanol
withdrawal-induced anxiety (Breese et al., 2004). During this pharmacological testing, one
distinct difference was noted between the stress/alcohol withdrawal protocol and the
repeated alcohol withdrawal protocol. This difference was that a 5-HT2C-receptor antagonist
did not block the cumulative adaptation induced by the repeated stress/withdrawal protocol
(Breese et al., 2004), as it did for the repeated withdrawal protocol (Figure 3;Overstreet et
al., 2003). Therefore, while results demonstrate considerable overlap in the neural
mechanisms responsible for the adaptation that supports sensitization of withdrawal anxiety
induced by the repeated alcohol withdrawal and stress/withdrawal protocols, it is equally
apparent that a difference in the neural control of adaptation by these protocols exists.
4.2. a. Consideration of cytokine mediation of stress facilitation of alcohol
adaptation—In addition to convincing evidence that CRF is involved in the action of
stress (Vale et al., 1981), literature has also shown that stress increases cytokines in brain
(Deak et al., 2005; Minami et al., 1991; Nguyen et al. 1998; O’Connor et al., 2003; Shintani
et al., 1995a; Shizuya et al., 1997; Suzuki et al., 1997). Others have expressed the view that
cytokines act as neuro-modulators (Adler et al., 2006; Bauer et al., 2007; Rostène et al.,
2007; Shintani et al., 1995b) and may contribute to depressive, anxiety and PTSD symptoms
(Anisman and Merali, 2003; Dunn et al., 2005; Hayley et al., 2005; Pucak and Kaplin, 2005;
Raison et al., 2006; Uddin et al., 2010.
To explore the possible involvement of cytokines in the action of restraint stress used for the
stress/withdrawal protocol, a single stress exposure nearly doubled the cytokine TNFα in the
cortex (unpublished data). Based upon this observation, the possibility was considered that
cytokines could substitute for stress to facilitate the alcohol adaptation responsible for
sensitization of alcohol withdrawal-induced anxiety. Upon substituting several cytokines for
the weekly stresses applied prior to 5 days of alcohol diet, Breese et al. (2008) found that
these selected cytokines (i.e., TNFα, IL1β, and CCL2) sensitized alcohol withdrawal-
induced anxiety (Figure 6). During this investigation, flumazenil administered prior to the
cytokine exposures prevented this sensitization of alcohol withdrawal anxiety—evidence
that the repeated cytokine exposure induced a cumulative adaptation, just as observed with
the repeated stress/withdrawal protocol (Breese et al., 2004). Additionally, anxiety was
observed during withdrawal from re-exposure to an additional 5 days of alcohol 16 days
after termination of the original protocol—evidence that the cytokine/alcohol withdrawal
protocol induced a persistent adaptation. Flumazenil administration prior to each of the
repeated cytokine exposures prevented this sensitization to re-exposure to alcohol—
evidence that this persistence depends upon the cumulative adaptation initiated by the
repeated cytokine/alcohol protocol (Breese et al., 2008). Given these observations, the
possibility is likely that cytokines released by stress contribute to the mediation of stress
sensitization of alcohol withdrawal-induced symptoms (Breese et al., 2008).
An impetus for continuing to define the role of cytokines in stress influences on alcohol
adaptation comes from a recent report that a genetic polymorphism occurs in the cytokine
gene for IL1β that is associated with alcohol dependence (Liu et al., 2009). Furthermore,
cytokines reportedly are elevated in plasma of alcoholics (Achur et al., 2010; Kiefer et al.,
1991). Most importantly, He and Crews (2008) found elevated levels of the cytokine MCP1
(CCL2) in alcoholic brain, evidence that cytokines could be contributing to ethanol
adaptation. Additionally, just as implied that alterations in CRF function are implicated in
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anxiety and depression (Hauger et al., 2009; Zobel et al., 2000; Zorrilla and Koob 2004),
literature has also proposed cytokine involvement in these central disorders (Anisman and
Merali, 2003; Dunn et al., 2005; Hayley et al., 2005; Pucak and Kaplin, 2005; Raison et al.,
2006). Section 5 notes that such symptoms are elicited to stress in the abstinent alcoholic.
Therefore, an intriguing consideration would be that the susceptibility of alcoholics to stress
induction of depressive and anxiety symptoms may be linked not only to CRF, but also to
cytokines (Fox et al., 2010).
In spite of the background consistent with cytokines contributing to the action of stress
(Breese et al., 2008; Anisman, 2009), a CRF1R antagonist prevents stress-induced
facilitation of ethanol adaptation (Breese et al., 2004). Integration of several reports may
provide a means by which CRF and cytokines could interact for involvement in the action of
stress to influence alcohol adaptation that would be prevented by a CRF1R antagonist. For
example, Del-Cerro and Borrell (1990) reported that the cytokine interleukin-1 facilitated
forced swim immobility, a “behavioral despair response”, which was minimized by
neutralization of CRF with anti-serum. Additionally, Wang et al. (2002, 2003) demonstrated
that CRF activation of CRF1Rs on microglia can facilitate release of cytokines. Thus, it is
hypothesized that stress release of CRF can cause a subsequent release of cytokines (Wang
et al., 2002, 2003), which in turn facilitate further CRF release (Del-Cerro and Borrell,
1990). In spite of background and knowledge that cytokines contribute to CRF control of
HPA axis activation (See Turnbill and Rivier, 1999), it remains unknown whether
sensitization of alcohol withdrawal anxiety that follows repeated cytokine exposures
depends upon a CRF mechanism. Given the importance of this postulate concerning
cytokine and CRF involvement in extra-hypothalamic function, future research can be
expected to resolve whether indeed cytokines acting as central neuromodulators (Adler et
al., 2006; Bauer et al., 2007; Rostène et al., 2007) depend upon CRF to contribute to the
stress-induced facilitation of alcohol adaptation (Breese et al., 2004, 2008).
4.3. Neuroanatomical sites involved in the repeated stress-induced facilitation of alcohol
withdrawal anxiety
Based upon CRF being released within the amygdala during withdrawal from alcohol
(Merlo-Pich et al., 1995) and finding that CRF mediates alcohol-withdrawal anxiety
(Baldwin et al., 1991) through actions within this structure (Rassnick et al., 1993), a strategy
was undertaken to identify brain sites at which CRF mediated the action of stress to sensitize
alcohol withdrawal anxiety. As before, the focus was on brain sites believed to be involved
in anxiety-like behavior that had a relationship to stress (Koob, 2003; 2008; 2009; Shin and
Liberzon, 2009). The approach taken was to microinject a CRF1R antagonist into selected
brain sites prior to each stress applied before the 5-day exposure to chronic alcohol (Huang
et al., 2010). As summarized in Figure 7, microinjection of a CRF1R antagonist into the
CeA, DRN, or dBNST prior to each weekly stress exposure prevented sensitization of
anxiety observed during alcohol withdrawal.
Following the results obtained with the CRF1R antagonist on stress facilitation of
withdrawal anxiety (Figure 7), CRF, as a substitute for stress, was microinjected into various
brain sites at a weekly interval prior to the single cycle of alcohol. This repeated site
administration of CRF into the CeA, the DRN, or the dBNST was found to sensitize alcohol
withdrawal-induced anxiety (Huang et al. 2010), providing further evidence for CRF
involvement in the action of stress to sensitize anxiety during alcohol withdrawal. In
contrast to the identification of brain sites positive for CRF action (Huang et al., 2010),
repeated microinjection of CRF into the hypothalamic PVN, the NAC, and the CA1 region
of the hippocampus prior to alcohol exposure did not support sensitization of alcohol
withdrawal anxiety (Huang et al., 2010). The CRF microinjection into the PVN being
without an effect provided further evidence that the HPA axis is not a component of the
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negative emotional state that accompanies withdrawal from chronic alcohol (Breese et al.,
2004). In another study, flumazenil administered into the amygdala prior to each stress
prevented the stress-induced cumulative adaptive process responsible for this sensitization
of alcohol withdrawal anxiety (Knapp et al., 2007). Presently unknown is whether
buspirone, which also prevents stress sensitization of anxiety (Breese et al., 2004) will do so
at a site where this drug prevented sensitization of withdrawal anxiety induced by the
repeated cycling of alcohol (See Figure 4).
Importantly, results obtained with CRF and the CRF1R antagonist administration into the
CeA are consistent with earlier work that supported an involvement of CRF in withdrawal
anxiety at this brain site (Baldwin et al., 1991; Rassnick et al., 1993); however, the other
CRF-positive brain sites identified had not previously been implicated in the anxiety
following alcohol withdrawal. When a CRF1R antagonist was administered systemically
prior to CRF microinjection into the CeA, the d-raphe (DRN) and the d-BNST, the
antagonist prevented the CRF-induced sensitization, just as this antagonist prevented stress
sensitization of withdrawal anxiety (Figure 7; Huang et al., 2010). Collectively, this work
not only supports the importance of the CRF1R being critical to the action of CRF and
stress, but also demonstrates that CRF action on this receptor subtype induces the
cumulative adaptation that supports sensitization of alcohol withdrawal anxiety. This latter
conclusion concerning the importance of the CRF1R in the action of CRF at these sites was
confirmed by finding that microinjection of urocortin3 into selected CRF-positive sites prior
to alcohol produced no sensitization of withdrawal anxiety (Huang et al., 2010).
CRF being without effect when microinjected into some brain sites, while having selectivity
to induce sensitization in several brain regions, supports brain region selectivity for
expression of anxiety—a conclusion noted with the microinjection studies performed for the
anxiety associated with withdrawal from the repeated cycling protocol (Section 2.3). Even
though this effort to identify brain sites involved in the sensitization related to CRF and
stress is important and informative, the results do not provide a definitive explanation for the
means by which CRF action in differing brain regions supports an adaptation responsible for
sensitization of alcohol withdrawal-induced anxiety. Consequently, just as proposed earlier
for repeated ethanol withdrawal adaptation, a future focus should be on how these various
brain sites interact within a neural circuit to allow stress to induce sensitization of anxiety
during ethanol withdrawal. Additionally, given a potential relationship between CRF and
cytokines mediating stress facilitation of ethanol adaptation, a future investigation should
define whether cytokine substitution for stress sensitization of alcohol withdrawal-induced
anxiety (Breese et al., 2008) depends upon those brain sites that support CRF sensitization
or whether cytokine action occurs at sites distinct from those sensitive to CRF (Huang et al.,
2010).
4.4. Influences of stress on alcohol consumption, the ADE, and reinstatement of alcohol
seeking: Drug actions and neuroanatomical substrates
For sometime, investigators have attempted to initiate greater drinking with stress as a
means to address the role of stress in alcohol ingestion predicted by the tension-reduction
hypothesis (Conger 1956). However, considerable controversy has existed concerning
whether stress can increase alcohol drinking. Pohorecky (1990) evaluated results obtained
on alcohol drinking by stress and concluded that stress applied when animals were drinking
alcohol resulted in minimal changes or a reduction in drinking. Nonetheless, more recently,
stress has been demonstrated to influence alcohol self-administration, the ADE, and
reinstatement of alcohol seeking. Because of the distinct characteristics of stress on these
models, stress influences on each are discussed separately.
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4.4. a. Effect of stress on alcohol self-administration—As mentioned above, in
acute paradigms commonly used in alcohol research, stress exposure leaves alcohol drinking
unaffected or even reduces it when applied while drinking. However, Lynch et al. (1999)
demonstrated that restraint stress increased alcohol intake in Wistar rats. While Chester et al.
(2004) reported that stress did not increase excessive drinking when applied during drinking,
excessive drinking was facilitated at a later time by the stress. Furthermore, when restraint
stress was applied during periods of abstinence from repeated cycling of voluntary alcohol
drinking of P-rats, a consistent accentuation of the ADE was observed (Breese et al., 2004;
Overstreet et al., 2007). An example of this facilitation of ADE is presented in Figure 8.
Importantly, during the final 5 days of drinking after stress application the level of intake
remains elevated rather than rapidly returning to baseline as is normally the case when only
cycling of voluntary alcohol drinking is performed (Overstreet et al., 2007). Following the
stress application during multiple cycles of voluntary alcohol drinking (ADE) in P-rats, the
stressed animals displayed sensitization of anxiety-like behavior during withdrawal from the
final drinking bout (Overstreet et al., 2007).
Other work has demonstrated that a prolonged history of voluntary access to alcohol alters
stress influences on alcohol drinking. For example, following 4 months of free-choice
drinking, which also included a cycle of forced deprivation, both forced swim stress and
footshock stress resulted in approximately a doubling of voluntary alcohol intake
(Vengeliene et al., 2003). Further, by evaluating the differing effects of stress in two rat lines
genetically selected for high alcohol preference, Vengeliene et al. (2003) effectively
demonstrated the importance of genetic background for stress influence on alcohol intake.
More recently, the effects of forced swim stress on subsequent alcohol consumption was
evaluated in Wistar rats with and without chronic intermittent alcohol vapor exposure that
induced dependence (Sommer et al., 2008). This effort demonstrated that alcohol intake was
unaffected by stress in animals without a history of dependence, whereas animals with a
history of dependence not only started out at a higher–escalated level of consumption, but
the stress induced a further increased in the voluntary alcohol intake. An intriguing
additional finding was that the stress-induced increase in drinking remained for an extended
period after the stress exposure was terminated (Sommer et al. 2008)—an outcome similar
to that previously reported (Valdez et al. 2003) (see also Section 3.1). Based upon this
observation by Sommer et al. (2008), an aspect needing clarification is whether producing
dependence to alcohol prior to stress exposure in the ADE protocol in P-rats will induce an
even greater facilitation in voluntary alcohol drinking than seen with stress alone (Overstreet
et al., 2007).
4.4. b. Drug actions and neuroanatomical support of stress on alcohol self-
administration—Even though the pharmacology and neurocircuitry of stressed-
potentiated drinking has generally been neglected, a link between stress escalation of alcohol
self-administration or consumption in dependent animals and increased behavioral responses
to stress in the post-dependent state are both selectively sensitive to inhibition by CRF1R
antagonists (Chu et al., 2007; Finn et al., 2007; Funk et al., 2007; Gehlert et al., 2007; Gilpin
et al., 2008b; Sommer et al., 2008). The importance of CRF in stress-induced alcohol
drinking was further emphasized by finding that a genetic variant of CRF in primates
increased alcohol consumption by stress (Barr et al, 2009). Surprisingly, CRF-deficient mice
consumed twice as much alcohol as wild type mice (Olive et al., 2003). Likewise, mice
lacking CRF1Rs exhibited enhanced drinking to stress that persisted (Sillaber et al., 2002),
another unexpected finding. An elevation of the NR2B receptor subunit was provided as an
explanation for the CRF1R deletion enhancing drinking (Sillaber et al., 2002).
Overstreet et al. (2007) examined the effect of several drugs on the stress-induced increase
in ADE in P-rats as well as on accompanying sensitization of alcohol withdrawal-induced
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anxiety. In this latter case, buspirone, flumazenil, and a CRF1R antagonist given prior to
each stress applied during deprivation from repeated cycling of voluntary alcohol drinking
successfully prevented the stress-induced facilitation of ADE as well as the sensitization of
anxiety observed during the final alcohol withdrawal (Overstreet et al., 2007). Of further
interest to the mediation of stress on drinking is the finding that a D2-dopamine receptor
antagonist and naloxone blocked the stress-induced increase in ADE without preventing the
stress-induced sensitization of withdrawal-induced anxiety during the final withdrawal from
this repeated voluntary alcohol ingestion (Overstreet et al., 2007)—an outcome that
contrasts with blockade of the repeated alcohol sensitization of withdrawal-induced anxiety
as well as the ADE by buspirone, flumazenil and a CRF1R antagonist (Breese et al., 2004;
Knapp et al., 2004, 2005; Overstreet et al., 2003, 2004a, 2007). Thus, distinct neural
mechanisms must contribute to the stress-induced cumulative adaptation responsible for
facilitation of the ADE and sensitization of alcohol withdrawal anxiety in the P-rats. Further,
genetic deletion of the neurokinin-1 receptors (NK1Rs) or blockade of NK1Rs to minimize
substance P (SP) action was found to markedly reduce voluntary alcohol consumption in
C57BL/6 mice (George et al., 2008; Thorsell et al., 2010). This observation is consistent
with reports that SP acting at NK1Rs within the amygdala complex mediates behavioral
responses to stress both in rodents (Ebner et al. 2004) and in humans (Furmark et al. 2005;
Michelgard et al. 2007). In Section 6, information will indicate that a NK1R antagonist
prevented challenge-induced symptoms in human abstinent alcoholics.
Just as investigations sought to define brain regions involved in the negative emotional state
observed during withdrawal from chronic alcohol (See Section 2.3), subsequent studies
sought to elucidate brain sites at which stress facilitated the ADE. Because CRF is a major
contributor to the actions of stress, initial studies utilized microinjection of CRF into various
brain sites during deprivation to identify sites supporting stress facilitation of the ADE and
the accompanying sensitization of alcohol withdrawal anxiety. Since CRF1R expression was
up-regulated within the amygdala as well as in other components of the extended amygdala
with alcohol dependence (Sommer et al., 2008), the CeA appeared to be a plausible site for
stress to facilitate alcohol drinking by the ADE. However, CRF microinjection into the CeA
did not support CRF-induced facilitation of the ADE, but did support sensitization of
alcohol withdrawal-induced anxiety (unpublished data). Likewise, CRF microinjection into
the raphe sensitized alcohol withdrawal anxiety without facilitation of the ADE. Given the
relationship of the ventral tegmental area (VTA) (Gatto et al., 1994; Rodd et al., 2004) and
the NAC to alcohol self-administration and responding for alcohol (Besheer et al., 2010;
Chaudhri et al., 2009), CRF was microinjected into these sites during deprivation from the
voluntary alcohol drinking to determine if the ADE would be facilitated. The repeated CRF
treatment into the NAC enhanced the ADE without altering anxiety during alcohol
withdrawal. Injection of CRF into the VTA affected neither measure. Subsequently, it was
determined that a CRF1R antagonist microinjected into the NAC prior to stress prevented
the stress-induced increase in the ADE, while being without an effect on stress sensitization
of alcohol withdrawal anxiety (Breese et al., 2010). This evidence that an action of stress in
the NAC increased drinking without inducing sensitization of alcohol withdrawal anxiety
negated a previous view that the degree of alcohol intake induced by stress during
intermittent voluntary alcohol drinking was responsible for the sensitization of alcohol
withdrawal-induce anxiety (Overstreet et al., 2007).
Additionally noteworthy is finding that CRF in the CeA is involved in facilitation of alcohol
self-administration in rats following alcohol physical dependence (Funk et al., 2006b).
However, as noted for non-dependent P-rats, the CeA is not involved in stress facilitation of
the ADE (Breese et al., 2010). Therefore, future efforts should attempt to clarify the
neurobiological basis for the dependence associated adaptation involving a brain site for
CRF facilitation of alcohol self administration distinct from that observed for the non-
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dependent P-rats. One aspect that could be explored would be whether stress facilitation of
alcohol self administration in physically dependent P-rats would involve both the CeA and
the NAC.
Demonstration of the site selectivity of CRF-related drinking and induction of sensitization
of withdrawal anxiety provides strong evidence that the neural mechanisms associated with
these central changes induced by stress can involve distinct brain regions. Yet to be
determined is whether buspirone and flumazenil, which also prevent stress facilitation of the
ADE, will act within the NAC to prevent the stress facilitation of drinking, just as observed
with the CRF1R antagonist, or whether other brain sites will be involved. Regardless of the
site of action of these drugs on the stress facilitation of the ADE, a presumption would be
that buspirone and flumazenil will prevent sensitization of withdrawal anxiety induced by
the stress facilitation of the ADE at sites where they minimized sensitization of anxiety
induced by intermittent chronic alcohol exposures (Figure 3; Knapp et al., 2007b;Overstreet
et al., 2006).
4.4. c. Influence of stress on reinstatement of alcohol seeking: Drug actions
and neuroanatomical substrates—As mentioned above (Section 3.3), stress can
reinstate alcohol-seeking behavior in rodents following extinction of operant self-
administration (Lê et al., 1998, 1999; 2000; Lê and Shaham, 2002; Liu and Weiss, 2002a,
2003; Martin-Fardon et al., 2000; Weiss et al., 2001), just as stress increased ADE. Lê et al.
(1998) reported that stress was a more powerful stimulus for reinstating alcohol seeking than
was an alcohol-priming dose. Further, Liu and Weiss (2002a, 2003) also reported that post-
alcohol dependent rats exhibit increased alcohol seeking behavior and a greater facilitation
of responding to stress—a finding consistent with other observations which demonstrated
that previous chronic alcohol exposure facilitates the consequences of stress on operant
reinstatement responding (Rimondini et al 2002; Sommer et al. 2008; Valdez et al 2003).
This latter outcome supports the concept (Breese et al., 2005a,c) that a persisting adaptation
that follows previous intermittent chronic alcohol exposures induces an allostatic state that
enhances responsiveness to a subsequently stress.
Liu and Weiss (2002a) demonstrated that a general CRFR antagonist inhibited stress-
induced reinstatement of alcohol seeking. However, this CRFR antagonist had no effect on
the increase in cue-induced responding in these previously dependent rats (Liu and Weiss,
2002a). Lê et al. (2000) was first to demonstrate that blockade of CRF1 receptor function
would prevent stress-induced reinstatement of alcohol seeking. More recently, Gehlert et al.
(2007) documented that CRF1R blockade prevented stress-induced alcohol seeking in post-
dependent rats. Consistent with CRF involvement in stress, CRF itself reinstated alcohol
seeking (Lê et al., 2000; Lê and Shaham, 2002). In further agreement with a link of stress to
CRF, the α2-adrenoceptor antagonist yohimbine, which potently induces anxiety responses
in alcoholics (Krystal et al. 1996), also reinstates alcohol seeking and induces excessive
alcohol self-administration in a CRF1R-dependent manner (Marinelli et al. 2007).
Consistent with CRF involvement in stress influences on alcohol, Funk et al. (2006a) found
that stress-induced alcohol reinstatement was associated with an increase in CRF mRNA in
the CeA and basolateral amygdala.
Additionally, Hansson et al. (2006) reported that Marchigian-Sardinian-prefering (msP) rats,
which have high alcohol preference, had an upregulation of the Crhr1 transcript in the CeA,
medial amygdala, and the basolateral amygdala that was accompanied by elevated CRF1R
density. These changes in CRF function in the msP rats were accompanied by an increase in
stress-induced increase in alcohol seeking that was blocked by a CRF1R antagonist
(Hansson et al., 2006), as was the increased alcohol self-administration in these msP rats.
However, the CRF1R antagonist was without effect in unselected Wistar rats on alcohol
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self-administration and did not suppress the stress-induce increase in alcohol seeking in
these rats (Hansson et al., 2006). Of interest is the down regulation of elevated Crhr1 mRNA
in various brain sites of msP rats after about 2 weeks of ad lib access to 10% ethanol
(Hansson et al., 2007). Collectively, these observations suggest that a genetic predisposition
for excess CRF function in the msP rats can mimic the neuroadaptation induced by a chronic
alcohol state (Sommer et al., 2008)—a circumstance that enhances the action of stress in
Wistar rats (Hansson et al., 2006).
Comparison of various other peptides or their antagonists on cue versus stress reinstatement
responding for alcohol has provided mixed results. Martin-Fardon et al. (2000, 2010)
reported that nociceptin was capable of reducing stress influences on reinstatement of
alcohol seeking as well as cue-induced reinstatement. A cannabinoid-1 receptor (CB1R)
antagonist reduced cue induced, but not stress reinstatement responding for alcohol
ingestion (Economidou et al., 2006b). Cippitelli et al. (2010) found that neuropeptide Y
(NPY) blocked alcohol reinstatement responding induced by yohimbine-induced stress, but
did not prevent cue-induced alcohol reinstatement responding. In previously dependent
Wistar rats, a mu-opioid antagonist effectively inhibited cue-induced reinstatement to an
alcohol paired lever, but was ineffective in blocking the stress-induced alcohol seeking (Liu
and Weiss, 2002a)—findings which contrast to the action of a CRFR antagonist on these
challenges (Liu and Weiss, 2002a). Such findings clearly denote that the mechanisms
driving cue and stress reinstatement responding for alcohol may have a differing neural basis
particularly after alcohol dependence. Ciccocioppo et al. (2009) have reviewed the potential
involvement of several peptides that may relate to stress and the consequences of chronic
alcohol.
5. Chronic Alcohol Neuroadaptation in Alcoholism: Relationship to Stress-
induced Negative Emotion and Craving in Alcoholism
In addition to neuroadaptations that underlie tolerance and alcohol withdrawal symptoms
associated with chronic alcohol, an additional clinical construct relevant to the desire to use
drugs of abuse was first described by Wikler (1948). In this respect, Wikler (1948) noted
that abstinent opioid addicted patients in residential treatment described an intense desire
and physiological need for opiates—a longing referred to as “craving”. Later studies in
abstinent alcoholics also documented a strong desire and intent to use alcohol (Ludwig et al.,
1974). This strong emotional and physiological need in the abstinent alcoholic that results in
this intense desire for alcohol ingestion was likewise defined as craving (Sayette et al.,
2000)—a hallmark feature of alcohol dependence. In the following sections, laboratory
challenges are described that reliably induce craving and alter physiological and neural
measures in alcoholics.
5.1. Stress increases susceptibility for craving and alters physiological measures in
alcoholics: A reflection of stress dysregulation
Basic studies reviewed in the previous sections clearly delineate that withdrawal related
physiological and affective changes occur that can persist for an extended period after
removal from alcohol exposure. In abstinent alcoholics, the “craving” to consume alcohol is
a common symptom precipitated by negative emotional states that follow stress (Breese et
al., 2005a; Brown et al. 1990; Cooney et al., 1997; Fox et al., 2005, 2007; Sinha, 2007;
Sinha & O’Malley, 1999) and alcohol cues (Cooney et al., 1987; Monti et al., 1987; Payne et
al., 1992). Furthermore, any craving induced by “stress” during acute alcohol withdrawal is
not only accompanied by a negative emotional state but as well by aspects of physiological
dysregulation, such as elevated levels of blood pressure, heart rate, and selected behavioral
symptoms. This susceptibility for craving to stress and alcohol cues persists in the abstinent
BREESE et al. Page 20













alcoholic. Importantly, upon alcohol removal other alterations are also known to persist for
an extended period in the alcoholic, including residual anxiety, negative affect, sleep
disturbances, and cognitive and behavioral changes (Brower, 2001; Drummond et al., 1998;
Sinha et al., 2009, 2010). The time required for normalization (recovery) of the neural
dysregulation in the alcoholic, which underlies the continuing susceptibility for craving to
stress or negative symptoms, remains unclear. Nonetheless, the sizable progress made from
these investigations resolved a lack of previous background on measures by which a
persisting adaptation induced by alcohol abuse and dependence could be evaluated.
In early studies, findings indicated that stress imagery elicited alcohol craving as well as
multiple emotions of fear, sadness and anger in alcohol addicted individuals, a change which
contrasted with the stress of public speaking that elicited increases in fear, but no anger and
sadness, and most importantly no increase in alcohol craving (Sinha and O’Malley, 1999).
In a comprehensive assessment of subjective, neuroendocrine and physiological responses to
exposure to stress and alcohol cues and neutral circumstances, the Sinha laboratory
demonstrated that abstinent alcoholics exposed to stress and alcohol cues reported alcohol
craving that was accompanied by anxiety, negative emotions and increases in physiological
measures and an elevation of cortisol and adreno-corticotrophic hormone (ACTH) caused by
activation of the hypothalamic pituitary adrenal (HPA) axis (Fox et al., 2007, 2009b; Sinha
and O’Malley, 1999). In this respect, alcoholics with a greater severity of alcohol abuse
show significantly higher stress and cue-induced alcohol craving, greater levels of stress and
cue-induced anxiety, and higher levels of physiological and neuroendocrine activation to
these challenges (Fox et al., 2009b). These data support the idea that a greater degree of
chronic alcohol abuse is associated with concomitantly increasing levels of anxiety and
craving as well as elevated alterations in physiological and biochemical indices of stress
arousal.
The Sinha Laboratory has also pursued the possibility that the persistence of
neuroadaptation associated with alcoholism contributes to compulsive alcohol seeking and
high relapse rates in alcoholism (Sinha, 2007; Sinha et al., 2009, 2010; Fox et al., 2009a).
Recovering alcoholics after 4-weeks of abstinence exhibit greater basal heart rate and
salivary cortisol levels compared to control drinkers. Upon stress and alcohol cue exposure,
alcoholics show persistently greater subjective distress, alcohol craving and blood pressure
responses, but a suppressed heart rate and cortisol response to stress compared to controls
(Sinha et al., 2009). In controls, the stress exposure did not increase alcohol craving, even
though they showed robust physiological and endocrine responses. On the other hand,
alcohol cue exposure in the controls produced a lower magnitude desire for alcohol than
observed in alcoholics without exhibiting a concomitant negative emotional distress or an
increased neuroendocrine response (Sinha et al., 2009, 2010). This assessment agrees with
previous reports that recently abstinent alcoholics or smokers not only display increased
craving (Yoon et al., 2006), but show an altered basal HPA axis level and a suppressed HPA
cortisol response to stress compared to their non-addicted counterparts (Al-absi et al., 2005;
Badrick et al., 2007; Junghanns et al., 2003; Lovallo et al., 2000; Munro et al., 2005).
Furthermore, continued monitoring of physiological and subjective responses across
multiple time points demonstrated that alcoholic patients show persistent stress-induced
increases in alcohol craving, subjective distress, and blood pressure changes compared to
stress in social drinkers—a finding suggestive of an inability of alcoholics to regulate their
state of emotional distress and physiological responses linked with elevated craving (Sinha
et al., 2009). These data support the view that stress-related alcohol craving and the
enhanced emotional distress observed during alcohol cue exposure are associated with
chronic alcohol use, but not with light to moderate alcohol exposure.
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In summary, the studies reviewed indicate that the enhanced susceptibility to stress and cue-
induced drug seeking observed in the alcoholic is not seen in healthy non-addicted
individuals. Furthermore, there are basal alterations in peripheral markers of stress in the
alcoholic which are indicative of stress-related dysregulation of CRF-HPA axis and
autonomic function. High morning basal salivary cortisol and heart rate levels were
observed in recovering alcohol-dependent patients that were associated with lower or
blunted stress-related arousal. Such a pattern of HPA and autonomic dysregulation is similar
to what has been documented in other chronic high distress states (Li et al., 2007; Steptoe
and Ussher, 2006). It is important to note that these alterations were not accounted for by
smoking status or lifetime history of anxiety or mood disorders; therefore, these changes
observed to stress can be attributed to chronic alcoholism. Additionally, the persistence of
emotional distress and alcohol craving induced by stress and alcohol cue exposure in the
dependent alcoholic suggests a dysfunction in mechanisms regulating emotion. Since stress-
induced HPA axis and autonomic responses are associated with regaining homeostasis,
dysfunction of these responses in the alcoholic can serve as markers of the dysregulation of
central stress mechanisms involved in perpetuating alcohol craving and relapse
susceptibility. Certainly, the dysregulation of stress responses resulting in high levels of
craving or compulsive alcohol seeking for an extended period in the abstinent, recovering
alcoholic is consistent with the concept that adaptation induced by chronic alcohol use is
dependent upon a sustained increase in allostatic load induced by a kindling-like process.
5.2. Gender differences in alcoholics to stress and alcohol cues
Sex differences are well documented in responses to stress as well as to changes induced by
abusive drugs (Becker et al., 2007; Kudielka et al., 2005). Therefore, Chaplin et al. (2008)
examined whether there were significant sex differences in the emotional stress responses
and alcohol craving in healthy social drinkers exposed to stressful, alcohol related and
neutral imagery. With this strategy, sex differences in emotional and physiological responses
to stress and alcohol cues were observed. Interestingly, in contrast to women who reported
greater sadness and anxiety in the stress condition, men showed a positive correlation
between emotional distress and alcohol craving (Chaplin et al., 2008). Diastolic, but not
systolic, blood pressure responses to stress were greater in men than women. Although men
reported somewhat higher levels of alcohol consumption than women, the level of alcohol
consumption did not account for this sex-specific association between negative affect and
alcohol craving (Chaplin et al., 2008). This greater vulnerability to alcohol craving in men is
consistent with other findings indicating a tendency of men having an inability to cope with
stress (Gentry et al., 2007; Lindquist et al., 1997; Tamares et al., 2002). In contrast to men,
women show rumination and negative thinking in stressful situations (Nolen-Hoeksema,
1987). These distinct tendencies seen with gender may contribute to the well known sex
differences observed in the prevalence of alcohol use disorders (Kessler et al., 1993; 1994).
When men and women who drink socially are compared to their abstinent alcohol dependent
counterparts on biological stress levels, Fox et al. (2009b) found clear sex differences in the
pattern of stress dysregulation associated with chronic alcoholism. Alcoholic males showed
increased ACTH and epinephrine basal tone compared with control males and alcoholic
females. However, the alcoholic males demonstrated no increase in ACTH and cortisol
levels following stress and alcohol cue imagery exposure compared to the neutral condition.
Control males and alcoholic females demonstrated a typical stress response in both
measures. In addition, alcoholic males showed no increase in cardiovascular responses to
either stress or cue, and no increase in catecholamine response to cue compared with their
response to neutral imagery. Again, this flattening of the stress response was not observed in
control males who produced significantly higher levels of cue-related heart rate,
epinephrine, and significantly higher stress-related diastolic blood pressure. In contrast,
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alcoholic females showed an enhanced ACTH and cortisol response to stress and an alcohol
cue compared with neutral imagery—a change that was not observed in the healthy control
females. Alcoholic females also showed blunted norepinephrine and epinephrine levels and
reduced heart rate to stress compared with healthy females. Therefore, while alcoholic males
show the previously discussed increased basal stress levels and a generalized suppression of
HPA cortisol, sympatho-adrenal response as well as markers of cardiovascular function
following both stress and alcohol cues, females showed a selective sympatho-adrenal
suppression to stress and an enhanced HPA response to both stress and alcohol cues (Fox et
al., 2009b). Interestingly, these differences in physiological and neuroendocrine patterns
were not seen in alcohol craving levels which were comparable across men and women.
These differential patterns of physiological and neuroendocrine findings with sex may
reflect involvement of distinct neurobiological processes in the compulsive alcohol craving
state in alcoholic men and women. Therefore, such manifested differences between men and
women should be an important consideration in therapy development for alcoholics of
differing sex.
5.3. Investigations of the relationship of craving and physiological measures to relapse in
alcoholism
The potential role of stress in increasing risk of alcohol relapse was initially support by work
showing that heavier drinkers, and not light drinkers, were more susceptible to stress-
induced alcohol consumption in laboratory situations (Marlat et al., 1975; Marlatt &
Gordon, 1980). In addition, alcohol-related stimuli or “cues” or alcohol itself are potent
factors to increase the risk of relapse in the alcoholic. Thus, it is not surprising that stress
and alcohol cues are associated with significant increases in alcohol craving and compulsive
alcohol seeking in the abstinent alcoholic—responses which in turn are predictive of alcohol
relapse (Cooney et al., 1997; Litt et al., 2000; McKay et al., 2005; Miller et al., 1996; Sinha,
2007; Tate et al., 2005; Zywiak et al., 2003). In alcoholics with varying levels of abstinence,
the degree of negative mood and stress-induced alcohol craving (Cooney et al., 1997, Breese
et al., 2005a; Sinha, 2007) as well as blunted stress-induced cortisol responses were
associated with alcohol relapse (Adinoff et al., 2005a,b,c; Brady et al., 2006ab; Junghanns et
al., 2003).
In a previous study with cocaine-dependent individuals, Sinha et al. (2006) examined
whether stress-induced cocaine craving in the laboratory significantly predicted time to
cocaine relapse. The findings indicated that stress-induced cocaine craving was indeed
predictive of a shorter time to relapse. In this study, stress-induced ACTH and cortisol
responses were not associated with time to relapse, but these responses were predictive of
amounts of cocaine consumed during follow-up. More recently, these studies were extended
to abstinent recovering alcoholics to understand whether the increased subjective distress
and alcohol craving is predictive of alcohol relapse. Sinha (2008b) prospectively followed
abstinent, alcohol dependent individuals who completed a 5-week inpatient treatment for a
90-day period post-discharge to assess whether laboratory craving and subjective and
biological responses to stress and alcohol cues were predictive of a later relapse to drinking.
Subjects returned for repeated assessments 14, 30 and 90 days after discharge with follow-
up rates of compliance of 96%, 89% and 92%, respectively. Findings indicated that both
stress-induced and alcohol cue-induced craving were predictive of time to alcohol relapse
(Sinha, 2008b). Furthermore, higher cortisol levels and cortisol/ACTH ratio (a measure of
adrenal sensitivity) across all conditions also significantly predicted a decreased time to
initial alcohol lapse (time to first drink) and time to relapse to the first heavy drinking day of
5 drinks or more in men and 4 or more in women. While a high basal HPA axis tone occurs
in alcoholics that is accompanied by a blunted HPA responsivity to stress (Sinha, 2008b),
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the higher morning basal HPA tone is a better predictor of time to alcohol relapse than is the
acute stress-related HPA response.
6. Imaging of Brain Regions Activated in Alcoholics by Alcohol Cues and
Stressful Imagery
Modell et al. (1990) proposed that alcoholics suffer from dysfunction of basal ganglia/limbic
striatal and thalamocortical neural circuits. Based upon this view that specific regions of the
corticostriatal limbic circuits would be altered during exposure to emotional stress and
alcohol cues in alcoholics, compared to social drinkers, brain imaging of alcoholic subjects
was initiated to determine if alcohol cues that resulted in craving could be associated with
specific regions of brain (Braus et al., 2001; George et al., 2001; Modell and Mountz, 1995;
Park et al., 2007; Schneider et al., 2001). As outlined below, these early investigations of
brain imaging in the alcoholic were the impetus to explore not only alcohol cues, but also
the consequences of stress on brain activity. Recently, drug testing has also been performed
on brain activity changes induced by alcohol cues in the alcoholic.
6.1. Brain regions activated by stress in alcoholics that initiate negative emotion and
craving: Evidence for neuroadaptation and alcohol relapse
An early study to measure blood flow with SPECT imaging found a change in the caudate
nucleus during induction of craving in alcoholics (Modell and Mountz, 1995). Subsequently,
George et al. (2001) found a greater increase in brain activity to alcohol cues in the anterior
thalamus and left dorsal lateral prefrontal cortex using functional magnetic resonance
imaging (fMRI). Using a memory task during fMRI to evaluate brain, Tapert et al. (2001)
found dysfunctional changes in the cortex of alcoholics distinct from that of controls.
Subsequently, other imaging studies with alcoholic patients showed an association between
increased activity of dorsal striatum regions and alcohol craving in response to presentation
of alcohol-related stimuli (Grusser et al., 2004; Wrase et al., 2002). Myrick et al. (2004)
reported that alcohol cues produced changes in the left orbital frontal cortex, anterior
cingulate cortex and NAC in alcoholics, which were not seen in control subjects. Figure 9
provides an illustration of brain imaging demonstrating the distinct fMRI response of an
alcoholic to an alcohol cue compared to the response in a corresponding control. The brain
regions exhibiting the greatest activation in the alcoholic were the right and left insula, the
right inferior frontal cortex, the left lingual cortex, and the right medial temporal cortex
(Gilman and Hommer, 2008). Additionally, PET imaging of alcohol-dependent individuals
demonstrated a significant association of D2-dopamine receptor binding in the ventral
striatum with alcohol craving (Heinz et al., 2004, 2005) and a motivation for self-
administration of alcohol (Martinez et al., 2005; 2007). To emphasize the importance of this
approach to investigating drugs of abuse, recent PET studies of D2-receptor binding have
shown significant positive correlations between selected dorsal striatum brain regions and
cue-induced cocaine craving (Wong et al., 2006; Volkow et al., 2006).
In investigations by the Sinha laboratory (Sinha, 2007; Sinha and Li, 2007), dependent
alcoholics abstinent from alcohol for 4-weeks were compared to social drinkers who were
exposed a single fMRI session. Using structured guided imagery, these participants received
two trials each of personalized stress, alcohol cues and neutral situations (Sinha et al., 2007).
Significant group main effects were observed in the ventromedial prefrontal cortex, insula,
the ventral striatum, and specific regions of the thalamus and cerebellum, with alcoholic
patients showing greater activity in limbic-striatal regions across the imagery conditions
(Sinha, 2007; Sinha and Li, 2007) and lower activity in the medial frontal and cingulated
regions. Specific condition effects were observed in the caudate and posterior cingulate
regions (Sinha, 2007; Sinha and Li, 2007). Consistent with this description of change in
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alcoholics (Sinha et al., 2007; Sinha and Li, 2007), Figure 10 provides visual examples of
the fMRI changes in neural activity observed in selected brain regions of alcoholics (AD) in
relation to changes in social drinkers (SD). Note the increased activity in the NAC/ventral
striatum region and in the insular cortex in the alcoholic in both the neutral and stress
conditions. In contrast, hypo-responsivity was observed to stress and alcohol cues in the
orbito-frontal cortex and the medial-prefrontal cortex (mPFC) in alcoholic brain compared
to the change in social drinkers (Figure 10).
Recently, Seo et al. (2010), using structured guided imagery and fMRI (Sinha et al., 2007)
found robust activity changes to stress and alcohol cues relative to the neutral condition in
the ventro-medial-PFC, dorsal-lateral PFC, cingulated cortex, amygdala, as well as several
other brain sites in the alcoholics. Hyper-responsivity within the ventro-medial-PFC,
anterior cingulated cortex and ventral striatum of the alcoholics during neutral relaxed states
was associated with a blunted response to stress and alcohol-cue exposure. Such hyper-
responsivity during relaxation within brain sites being accompanied by blunted responses
during stress predicted stress- and alcohol cue-induced craving and concomitant anxiety.
This difference in brain responses between the neutral imagery and stressful cues shown in
alcohol-dependent patients is suggestive of a poor ability to differentiate between
challenging and relaxed states (Sinha et al., 2007; Sinha and Li, 2007). Importantly, both the
hyper-responsivity of the ventral-medial-PFC and anterior-cingulated cortex during neutral
relaxed states and the blunted response during stress were also predictive of a greater
propensity for a shorter time to relapse (Seo et al., 2010).
The fMRI findings in abstinent alcoholics, which show an overall hyper-responsivity of the
striatal-limbic regions associated with emotion processing, but hypo-responsivity in medial
frontal regions associated with emotional regulation, self control, and executive functioning,
likely accounts for the central dysregulation that accounts for the increased susceptibility for
relapse (Sinha, 2007; Sinha and Li, 2007; Seo et al., 2010; Figure 10). Such central activity
changes in these brain sites of the alcoholics are consistent with an overall kindling process
increasing an allostatic load that results in this dysfunction in neural processing. Therefore,
it can be presumed that normalization of these alcohol dysregulated brain regions is critical
for restoring integration of emotional and motivational functions. Consequently, normalizing
this dysfunction within these brain sites in the alcoholic would be an important strategy for
improving recovery and minimizing relapse to alcohol abuse. In 6.2 to follow, a particularly
promising approach to identify potential new pharmaco-therapies is to employ testing drug
inhibition of craving and brain imaging changes induced by stress and alcohol cues in
alcoholics.
6.2. Drug treatments on brain imaging in alcoholics to stress and alcohol cues: Approach
for human drug testing
While several efficacious behavioral and pharmacological therapies in the treatment of
alcoholism exist, it is well known that relapse rates in alcoholism remain high (Sinha, 2001;
O’Brien, 2005; Vocci et al., 2005). Exposure to stress, alcohol-related stimuli and alcohol
itself can each reinstate drug-seeking behavior in animals and increase relapse susceptibility
in alcohol dependent individuals (Sinha, 2007; Shaham and Hope, 2005; Shaham et al.,
2003; Weiss, 2005). Such data underscore the need for a specific understanding of the
phenomena of relapse susceptibility in order to target development of pharmacological
therapeutics that can minimize this liability alcoholics have for relapse. Findings from basic
science laboratories have identified several pharmacological treatment targets to address
stress-induced anxiety and reinstatement of drug seeking. As noted in Sections 2 & 3, basic
science data suggest that CRF1R antagonists, α2-adrenergic agonists, buspirone, baclofen, a
NK1R antagonist and selected glutamatergic agents could be promising treatments to
address stress-related relapse in alcoholism. Therefore, human laboratory investigations are
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needed that will screen these agents in alcoholics to assess their potential efficacy on
surrogate markers that predict suppression of stress-related relapse.
A particularly promising strategy for identification of new pharmaco-therapies would be to
determine if drugs, which have been found to have efficacy in preclinical investigations
against models of alcohol action, would prevent stress- and alcohol cue-induced craving,
craving related anxiety, HPA measures, heart rate variability as well as the brain imaging
changes in specific brain regions induced by these stressful challenges (Sinha, 2007; Sinha
and Li, 2007). Thus, future human laboratory studies are needed that will screen new as well
as established agents in alcoholics to assess their effectiveness against the stress and cue-
induced changes. The next course would be to determine whether actions on these measures
associated with the alcoholic would be predictive of minimizing or preventing relapse.
Given that human laboratory investigations have documented the neural and physiological
changes induced in alcoholics by stress and alcohol cues, this strategy outlined could be a
potentially powerful approach for identifying drugs for further clinical testing against the
susceptibility for relapse observed in alcoholics.
From preclinical background, an obvious candidate mechanism to target alcohol-induced
neuroadaptation in alcoholism would be antagonism of CRF1Rs. Based upon preclinical
evidence that CRF1Rs are involved in the increased stress responsiveness in rodents (Breese
et al., 2005b; Sommer et al. 2008; Valdez et al., 2002), it can be predicted that testing of a
CRF1R antagonist would reduce craving and exaggerated brain responses to stress in
alcohol-dependent patients. However, clinical testing of CRF1R antagonists to reduce
relapse in alcoholism is only now being considered. Nonetheless, as noted in Section 4.4b,
substance P (SP), like CRF, has been found to have an involvement in stress responsiveness
(Ebner et al. 2004; Furmark et al. 2005; Michelgard et al. 2007) and in ethanol drinking
(George et al. 2008). Consequently, given the similarities of CRF and SP to stress, the
assumption was that some insight might be gained by investigating whether SP mediation
influences behavioral and functional neural responses of alcoholics to stress and alcohol
cues.
Based upon this background, the NIAAA intramural clinical program tested a whether a
NKIR antagonist administered to human alcoholics would affect alcohol craving and brain
imaging responses to negative affective stimuli (George et al. 2008). This investigation
demonstrated that pharmacological blockade of NK1Rs in alcohol-dependent patients
suppressed subjective cravings for alcohol and cortisol responses induced by exposure to
stress and alcohol associated stimuli (George et al. 2008). Figure 11 documents that the
NK1R antagonist normalized the exaggerated brain responses to the negative affective
stimuli in key brain regions in this alcoholic population, including most importantly the
metabolic changes in the anterior insula induced by the stimuli (George et al. 2008; Figure
10). This latter structure is of particular interest because it is reciprocally interconnected
with the amygdala, encodes aversive interoceptive states, and has been implicated in
mechanisms of craving and relapse (see review by Naqvi and Bechara, 2009).
This pioneering approach taken by George et al. (2008) to evaluate a drug action on stimulus
induced craving and changes in brain imaging of alcoholics demonstrates the potential of
this proposed clinical model to identify potential compounds for extended clinical testing in
alcoholism. Obviously, the next step would be to test the degree to which this strategy
predicts whether a drug effective in this proposed model of drug evaluation is capable of
minimizing the high susceptibility of relapse observed in alcoholics. In this respect, the
results obtained by George et al., (2008) would warrant a future investigative clinical trial to
assess if this NK1R antagonist would minimize relapse in alcoholic patients, particularly
those who demonstrate anxiety and depressive symptoms during abstinence. Certainly,
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future inclusion of this proposed strategy of clinical testing of drugs identified with an action
against the craving and the brain change in fMRI in alcoholics to stress and alcohol cues is
worthy of pursuit to determine if these drugs would indeed affect the degree of susceptibility
for relapse.
7. Implications that Understanding “Kindling/Allostasis-Like”
Neuroadaptation Induced by Alcoholism Provides Optimism for Future
Treatment
The background material provided clearly outlined several aspects that contribute to the
alcoholic state (Section 1.1). Contributions by genetic susceptibility, early environmental
adversity, drinking during adolescence, or co-morbidity with other stress- related psychiatric
disorders are factors that have been linked to susceptibility for alcoholism. Based upon this
diversity of factors associated with alcoholism, there have been several efforts to classify
alcoholics (Cloninger et al., 1981; Heilig, 2008; Penick et al., 1990; and see Report from
NIAAA). Regardless of the classification or basis of the alcoholism, excess ingestion of
alcohol over time facilitates negative emotions during abstinence, resulting in an escalation
of future alcohol use. Heilig et al. (2010a) have reviewed aspects of acute withdrawal,
negative emotion and protracted symptoms observed during abstinence in the alcoholic.
Preclinical data support the view that worsening of withdrawal symptoms during periods of
abstinence in the alcoholic results from a cumulative adaptation by intermittent alcohol
exposures. This adaptive process by alcohol has been shown to facilitate alcohol self
administration. A critical conclusion from such preclinical studies is that consequence of
chronic alcohol depends upon adaptation by a kindling-like process that increases an
allostatic load (Koob, 2003; Breese et al., 2004, 2005c). Importantly, stress alone substitutes
for initial alcohol withdrawals to produce a cumulative adaptation that sensitizes anxiety-
like symptoms during withdrawal from alcohol. To illustrate that mediators of stress induce
a cumulative adaptation that increases alcohol adaptation, literature demonstrated that
repeated CRF and cytokines, like stress, sensitize withdrawal symptoms by facilitating
adaptation of a single chronic alcohol exposure that alone was without effect. Consequently,
stress facilitation of ethanol adaptation may provide a basis for the elevated susceptibility
individuals with various “stress-related disorders”, such as depression, anxiety disorders or
post-traumatic stress disorder, have for alcoholism.
A critical component of clinical findings in alcoholics under treatment is their extraordinary
relapse rate to abusive drinking. An important clue for this susceptibility for relapse of
alcoholics was the demonstrated craving in alcoholics challenged with stress or alcohol-cues
(George et al. 2008; Seo et al., 2010; Sinha, 2001; Sinha et al., 2009, 2010). Subsequently,
specific brain regions in the alcoholic were shown to be activated by these challenges, a
change which is not observed in social drinkers. These data have provided convincing
clinical evidence that the brains of alcoholics are altered by persistent alcohol abuse.
Further, documentation of accompanying dysfunction of the HPA axis and of blood pressure
reaction to stress in the alcoholic, with these distinct alterations in specific brain sites,
clearly provided further support for the view that a persisting adaptation is present after the
extended use of alcohol (Sinha et al., 2009). Importantly, these demonstrations of altered
functions being persistently present in alcoholics are consistent with the proposed allostasis/
kindling hypothesis of alcoholism (Breese et al., 2005c).
As treatment strategies for alcoholism are investigated, the extent of the persisting
adaptation in brain by alcohol abuse must be considered. An argument is made that there is a
strong relationship between the degree of craving induced by the alcoholic and relapse. Base
upon finding that administration of a drug prior to brain imaging can prevent changes in
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brain of alcoholics to stress, utilization of drug action on brain imaging changes induced by
alcohol cues in the alcoholic may be a useful approach for identifying new agents that can
disrupt both the craving as well as the altered brain response to stress and alcohol cues. In
this regard, George et al. (2008) demonstrated the feasibility of this approach. Hopefully,
drugs found effective in minimizing the susceptibility shown by alcoholics to stress and
alcohol cues will be found to reduce the degree of relapse. Nonetheless, future investigations
remain to determine whether identified drugs, which minimize craving and the changes in
brain responses in the alcoholic, will indeed minimize relapse and loss of control.
In closing, the neurobiology that provided a theoretical basis for the increased susceptibility
alcoholics have to stress has primarily evolved in the past decade. In particular,
identification of brain regions being associated with specific symptoms of withdrawal and to
stress challenges can be expected to facilitate identification of treatments that will minimize
the vulnerability of the alcoholic for relapse. Although addictions to other drugs would be
expected to have a differing neurobiological basis from that of alcohol, many of the same
drugs that interrupt stress-induced responding to alcohol in animals also minimize
responding induced by other addicting drugs (see Aujla et al., 2008; Shaham et al., 2003).
Therefore, defining the basis of the similarities of treatments effective in both circumstances
of drug and alcohol addiction may be critical to isolating effective therapies to minimize
relapse in alcoholism. Convincing basic evidence for ethanol inducing a kindling/allostasis-
like adaptation has provided a biological basis for the persistent pathology associated with
chronic alcohol abuse. Based upon this background, the documentation that stress and
alcohol cue-induced craving in alcoholics is associated with an altered neurobiology of brain
provides optimism for future research establishing a means by which the disease of
alcoholism can be treated and controlled.
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Figure 1. Comparison of three repeated cycles of alcohol (ETOH) with 1 ETOH cycle and
continuous (Contin) ETOH diet on social interaction—a measure of anxiety-like behavior
Social interaction was measured 5–6 hrs after ETOH removal. P < 0.01 compared to Control
Diet (CD) and the other ETOH exposed groups. Modified from Overstreet et al. (2002) by
permission of publisher.
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Figure 2. Social interaction after withdrawal from alcohol (ET) re-exposure of rats previously
exposed to repeated cycling of alcohol
Animals were given three cycles of 5 days of 7% alcohol diet (ED-CY3) followed by an
additional 5 days of alcohol diet 8 or 16 days after the initial repeated alcohol exposure (ED-
CY3-R-8D & ED-CY3-R-16 D). CD rats received only control diet. The CY1 is withdrawal
from a single cycle of alcohol diet to animals that previously received CD. Social interaction
as a measure of anxiety-like behavior was measured 5–6 hrs after withdrawal from the re-
exposure to alcohol diet. * P < 0.01 compared to CD and CY1. Modified from Overstreet et
al. (2002) by permission of publisher.
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Figure 3. Treatment of a 5-HT2C inverse agonist, a 5-HT1A agonist, or a BZD antagonist into
either the dorsal raphe or the amygdala on sensitization of alcohol withdrawal-induced anxiety-
like behavior
Dorsal Raphe data are at the top and amygdala data are presented in the bottom illustration.
The 5-HT2C inverse agonist (SB243213; SB), the 5-HT1A agonist (buspirone), and the BZD
antagonist (Flumazenil; Flu) were administered into the sites during withdrawal from the
initial two cycles. Social interaction as a measure of anxiety-like behavior was measured 5–
6 hrs after withdrawal from the final cycle of alcohol. * P < 0.01 compared to control diet
exposure. Modified from Overstreet et al (2006) and Knapp et al. (2007) by permission of
the publishers.
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Figure 4. Repeated Stresses Sensitization of alcohol (ET) withdrawal-induced anxiety
The (Control Diet) group received only diet. The (No Stress-1 cycle ET) group received no
stress and and only 1 cycle ET. The (Control Diet-3 Stress) group received 3 separate 60
min stresses at weekly intervals. The (2 Stresses—1 cycle ET) group was exposed to two 60
min restraint stresses at a weekly interval followed by exposure to 1 cycle of 5 days of 4.5%
alcohol diet. Social interaction as a measure of anxiety was measured 5–6 hrs after removal
of alcohol diet or the final stress. * P < 0.01 compared to all other groups. From Breese et al.
(2004) by permission of publisher.
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Figure 5. A CRF1R antagonist, a BZD receptor antagonist and a 5-HT1A agonist prevent the
repeated stress sensitization of alcohol (ETOH) withdrawal anxiety
The CRF1R antagonist was CRA1000, the BZD antagonist was flumazenil (FLU) and the 5-
HT1A agonist was buspirone. For each of the drug groups the drug was administered prior
to each stress given prior to 5 days of 4.5% ethanol diet (ETOH) Social interaction as a
measure of anxiety-like behavior was measured 5–6 hrs after ETOH Diet removal. * P <
0.01 compared to all other groups. From Breese et al. (2004) by permission of publisher.
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Figure 6. Repeated cytokines sensitize alcohol-withdrawal anxiety (decrease social interaction)
Rats were injected with individual cytokines [CCL2 = chemokine (C-C motif) ligand 2;
IL1β = interleukin-1β; TNFα = tumor necrosis factor-α] at a weekly interval prior to
exposure to 5 days of 4.5% alcohol diet (ED). CD VEH = vehicle during control diet; ED-
Veh = vehicle prior to alcohol diet. CD-CCL2 = CCL2 given weekly during control diet
exposure. Social interaction as a measure of anxiety-like behavior was determined 5–6 hrs
after alcohol removal. * P< 0.001 compared to CD-Veh and ED-Veh groups. From Breese et
al., (2008).
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Figure 7. Microinjection of a CRF1-R antagonist (SSR) into the CeA, DRN, or dBNST prior to
restraint stress prevents sensitization of alcohol withdrawal-induced anxiety-like behavior
(reduction in social interaction)
The CRF-1 receptor antagonist SSR125543 (SSR; 10 μg/0.5 μl) was microinjected into the
CeA, DRN, or the dorsal BNST (BNST) 15 min prior to the 2 weekly 60-min restraint
stresses applied before exposure to 5 days of 4.5% alcohol diet (ED). For the CD-Vehicle
and ED-Vehicle groups, vehicle was administered into each of the brain sites (N = 3–6 for
each site) and these data combined. Social interaction, as a measure of anxiety-like behavior,
was determined 5–6 hrs after alcohol removal. The CD-Vehicle group was not significantly
different from the ED-vehicle group. *P < 0.001 when compared to the CD-Vehicle, ED-
Vehicle, and CD Stress groups as well as the groups that received the CRF1R antagonist
(SSR) into the three brain sites prior to the repeated stresses. From Huang et al. (2009) by
permission of the publisher.
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Figure 8. Stress during withdrawal from repeated voluntary alcohol drinking facilitates the
Alcohol Deprivation effect (ADE)
P-rats were given either continuous voluntary access to water and alcohol solution (10%) or
3 cycles of voluntary access to water and alcohol solution with 2 days of abstinence between
the 1st two cycles. Intake of alcohol was subtracted from intake on the final 5 days of fluid
ingestion.
*Significantly different from Continuous. +Significantly different from Cycling Only.
Modified from Breese et al. (2004) by permission of the publisher.
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Figure 9. Sensitized brain responses to aversive visual stimuli healthy controls and in alcohol
dependent patients approximately 3 weeks into abstinence
Among 10 distinct areas altered (Gilman and Hommer, 2008), the brain regions exhibiting
the greatest activation (P< 0.001) in the alcoholic were the right and left insula, the right
inferior frontal cortex, the left lingual cortex, and the right medial temporal cortex.
Reproduced with permission from Gilman and Hommer, 2008).
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Figure 10. Functional magnetic resonance imaging (fMRI) responses during exposure to stress
(S), alcohol cue (C; Cues), and neutral relaxing (N; Neutral) imagery trials
Twenty-eight recently abstinent alcohol dependent (AD) and 24 healthy social drinkers (SD)
are included in the trials. Whole brain voxel-based mixed effects model analyses for
significant Group 2 (AD, SD) main effects and Group X Condition 3 (S, C, N) interaction
effects are shown for the selected brain regions at specified thresholds of significance (p<.
05, p<.01, p<.005 as noted). Talaraich coordinates (x,y,z) designate the center of activation
in each brain region. Whole brain voxel based maps for main and interaction effects are
followed by group difference maps (AD minus SD) depicted in the right three images for
each test condition (Neutral, Stress, Alcohol Cue).
For (a), the nucleus accumbens/ventral striatum (NAc/VS) region, a significant group main
effect is shown at two separate thresholds ([i] p<.05; [ii] p<.01 on the left in red/yellow).
Simple effect contrasts show greater activation in AD subjects than SD controls in the
neutral and stress conditions (p<.01; depicted in red/yellow), but not in the alcohol cue
condition (i.e., the three images shown on the right). For (b), the orbitofrontal cortex (OFC),
a significant group main effect was seen at two separate thresholds ([i] p<.05; [ii] p<.01
shown on the left). Simple effects to explain this significant group effect in the OFC
indicated lower activity in AD patients relative to SD controls as shown in pink for the OFC
region across all three conditions (p<.01; AD less than SD).
For (c), the left insula region, the Group X Condition significant interaction effect is shown
on the left in red/yellow at [i] p<.01 and [ii] p<.005 thresholds. Simple effect contrasts to
explain the significant interaction effect indicated greater activity in AD patients relative to
SD controls in the neutral and stress condition shown on the right (significant contrast area
shown in red/yellow, p<.01), but not in the alcohol cue condition.
For (d), the medial prefrontal cortex (mPFC) region, group by condition significant effect is
shown on the left in red/yellow at [i] p<.005 and [ii] p<.01 thresholds. Simple effect
contrasts to explain this significant interaction effect indicated that it was a result of lower
activity in mPFC in AD patients relative to SD controls in the stress and alcohol cue
conditions shown in pink on the right (p<.01) and not due to a activity change in the neutral
condition.
BREESE et al. Page 55













Figure 11. NK1R antagonist (LY686017) blockade of fMRI BOLD responses to visual affective
stimuli in hospitalized alcoholics
In the placebo group of alcoholics, there were robust significant activations to the
application of the negative stimuli in the inferior frontal gyrus, insula, and middle temporal
gyrus. The NK1R antagonist-treated group (LY686017) had significantly less activation in
these areas. Likewise, the placebo control group had little activation in response to positive
emotional stimuli. The NK1R antagonist group of controls exhibited activation in the
thalamus, caudate (including the ventral putamen), lingual gyrus and several temporal areas
(see George et al., 2008 for details). Modified from George et al. (2008) by permission of
the publisher.
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